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Abstract 
 
Persistent, bioaccumulative, and toxic (PBT) substances are a continuing cause of concern 
because of their effects on environmental and human health. The objectives of this pilot study 
were (1) to develop a screening method that could be used for the extraction and analysis of a 
group of 10 PBT compounds selected from the priority lists of Muir and Howard (2007) and (2) 
to apply those methods to measure the concentrations of these analytes in lake trout collected 
from Lake Michigan. These compounds included 1,2,3,4,5-pentabromo-6-chlorocyclohexane 
(PBCCH); 1,2,5,6,9,10-hexabromocyclododecane (HBCDD); 1,2,3,4,5,5-hexachloro-1,3-
cyclopentadiene (HCCPD); 3,4,4'-trichlorocarbanilide (TCCBA); 3,4-dichlorobenzotrifluoride 
(DCBTF); 4-chloro-3,5-dinitrobenzotrifluoride (CDNBTF); triphenylphosphine (TPPine); 2,4,6-tri-
tert-butylphenol (TTBP); dodecamethylpentasiloxane (DDMPS); and 
dodecamethylcyclohexasiloxane (DDMHS). Difficulty was encountered in obtaining reference 
materials for TTBP and DDMHS. Thus, triphenylphosphite (TPPite) was substituted for TTBP, and 
DDMHS was omitted from the list.  
 
Standard solvent extraction, gel permeation chromatography (GPC), and silica gel 
chromatography (SGC) methods were applied and modified as necessary for the clean-up 
preparation of fish samples. This included a serial evaluation of GPC elutants, which indicated 
the 150 to 350 mL fraction yielded the best results. Subsequently, an evaluation of SGC elutants 
revealed that the first two fractions combined yielded the best results. After solvent extraction, 
the quality control and fish samples were analyzed via gas chromatography/mass spectrometry 
(GC/MS) along with a set of calibration standards. 
  
DCBTF, DDMPS, and HCCPD produced symmetrical, well-shaped peaks and well-defined 
spectra. HBCDD performed acceptably well and was detectable at 10 to 50 pg/µL. PBCCH 
chromatographed well, but it produced two peaks, both of which were detectable at 
approximately 50 pg/µL. The spectra of the two peaks suggested that the compounds were very 
similar in structure; the reference material was a technical grade product that could have 
consisted of a mixture of isomers. CDNTFMB (2-chloro-1,3-dinitro-5-[trifluoromethyl]-benzene) 
did not chromatograph well and results were quite variable. Both TPPine and TPPite exhibited 
some degradation during the instrumental analysis. TPPine produced only one peak, identified 
as triphenylphosphine oxide (TPPineO); the chromatography was acceptable and the compound 
was detectable at 50 pg/µL. Triphenylphosphine was detected at 10 ng/µL, although the peak 
shape was poor and the major component in the chromatogram was TPPineO. Injection of 
TPPite yielded two peaks, one identified as TPPite, and the second identified as 
Triphenylphosphate (TPPate). TCCBA was not detected at ppb levels. When injected at ppm 
levels, several peaks were present in the chromatogram. It was speculated, based on their 
spectra, that they were fragments of TCCBA. 
 
The surrogates indicated that the method was functioning as expected for all of the quality 
control and fish samples. In the analyses of reagent blanks, DDMPS, HCCPD, TPPate, and 
TPPineO were present even though they had not been added to the samples. This may indicate 
contamination in one or more of the reagents, or that some component of the reagents was 
xi 
interfering with the analytes. Although reagent spike recoveries were low or nonexistent, this 
was expected as several of the compounds were not detected at the spiking level. Similarly, 
spiked samples recovered low, if at all. Conversely, TPPate recovered up to 700 times higher 
than the theoretical spike level. In general, spiked sample duplicate recoveries were low or 
nonexistent. DDMPS recovered well in three of four samples, whereas TPPate recovered 
extremely high in those same samples.  
 
Six of the compounds were detected in one or more tissues from the six lake trout samples. 3,4- 
DCBTF was detected, albeit at very low levels in the tissues of two fish, and HBCCD was 
detected in the muscle of one fish. DDMPS was detected in all tissue samples from all of the fish 
examined. HCCPD, TPPate, and TPPineO were observed in one or more tissues of all six fish. 
Given the ostensible PBT nature of these chemicals, further refinement of the analytical 
methods and examination of these compounds in the Great Lakes environment appear 
warranted.  
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1 
Introduction 
 
Persistent, bioaccumulative, and toxic (PBT) substances are a continuing cause of concern 
because of their effects on environmental and human health. Though the concentrations of 
banned legacy compounds such as PCBs and DDT have declined in many regions, other 
“emerging,” or as-yet-to-emerge, contaminants are beginning to come under scientific and 
regulatory scrutiny. Wong (2006) defined emerging contaminants as chemicals (including 
veterinary and human pharmaceuticals) that currently are being used and released into the 
environment and are a cause of special concern due to their widespread occurrence and 
potential for toxic effects. Emerging contaminants also include metabolites (break down 
products produced as chemicals or other organic compounds are metabolized) of past-use 
chemicals and mixtures, both of which are poorly understood. 
 
In an effort funded by the U.S. Environmental Protection Agency’s (USEPA) Great Lakes National 
Program Office (GLNPO), Muir and Howard (2007) compiled a list of emerging and PBT 
substances that needed research and monitoring attention. This “Great Lakes” relevant list, 
compiled from the Canadian Domestic Substances (DSL), EPA High Production Volume (HPV), 
and the Enhanced HPV (EHPV) lists and several lists of chemicals known as Unknown or Variable 
Composition Complex Reaction Products and Biological Materials (UVCBs), includes 22,043 
known chemicals produced as parent compounds or reaction products from the mid-1980s 
through 2002.  
 
Selected physical and chemical property values of the compounds were estimated with the 
USEPA Estimation Program Interface (EPI) Suite software (Muir and Howard, 2007). The 
database was sorted and chemicals prioritized according to characteristics that are important in 
a Great Lakes context, including parameters such as persistence, bioaccumulation, and 
atmospheric transport potential. The compounds were then compared with the Toxics Release 
Inventory (TRI) and the National Pollutants Release Inventory (NPRI) to identify chemicals that 
could potentially be detected by available analytical methods. After an initial screening, 
chemicals on the high production volume list were reevaluated, and a final list of 429 
compounds was established. Of these, 69% were halogenated and 12% were siloxanes, which 
reflected the higher persistence and bioaccumulative nature of these classes of compounds. 
 
According to Muir and Howard (2007), only 83 of these chemicals have been measured in the 
environment of the Great Lakes region, and only 16 were routinely measured. Clearly, there is a 
need to determine the presence, and ultimately the environmental fate, of many more 
chemicals in the Great Lakes environs. Muir and Howard (2007) further reduced their list of 429 
potentially problematic chemicals to 50 priority compounds based on production volume, 
bioconcentration factor, and persistence. These 50 chemicals are represented by the following 
classes: brominated, chlorinated, fluorinated, silicones, and non-halogenated. These chemicals 
exhibit a wide array of physical characteristics. Some appeared to be polar and others nonpolar, 
some had high molecular weights and some were smaller with low molecular weights, some 
were ionic and others covalent in nature. The authors note that analytical method development 
or refinement is needed for many of these compounds.  
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One of the objectives of this project was to develop a screening method that could be used for 
extraction and analysis of a group of analytes as opposed to developing numerous methods 
that each target only one compound. The second objective of the project was the application of 
the laboratory procedures to measure the analytes in lake trout collected from Lake Michigan. 
Lake trout are long-lived, predatory fish known to accumulate environmental contaminants to 
high concentrations, and consequently, is a key species in the USEPA Great Lakes National 
Program Office’s Great Lakes Fish Monitoring Program.  
 
  
3 
Methods 
 
Selection of Analytes 
The analytes for this project were selected based on their predicted lipophilic tendencies and 
volatilities. In general, if a compound appeared to be nonpolar or soluble in a nonpolar solvent 
such as hexane or isooctane, it was considered a potential analyte. If the compounds have a 
boiling point below 350° to 400°C, they are in the class of semivolatiles, which are generally 
amenable to analysis by gas chromatography. 
 
The Illinois Sustainable Technology Center (ISTC) has the capability to conduct an analysis of 
semivolatile compounds that are expected to be in the lipid extracts of biological samples. A 
number of ISTC’s existing procedures for the analysis of lipophilic compounds are based on the 
following USEPA SW846 methods. 
 
 3545A - Pressurized Fluid Extraction (PFE)  
 3640A - Gel-Permeation Cleanup 
 3630C - Silica Gel Cleanup 
 8270D - Semivolatile Organic Compounds by Gas Chromatography/Mass Spectrometry 
(GC/MS) 
 8290A - Polychlorinated Dibenzodioxins (PCDDs) and Polychlorinated Dibenzofurans 
(PCDFs) by High-Resolution Gas Chromatography/High-Resolution Mass Spectrometry 
(HRGC/HRMS) 
 USEPA Method 1668, Revision A: Chlorinated Biphenyl Congeners in Water, Soil, 
Sediment, and Tissue by HRGC/HRMS 
 
All of the compounds chosen for this project were “analyzable by using existing methods for 
neutral [persistent organic pollutants] or other neutral [compounds] such as pesticides, i.e., no 
derivatization” (Muir and Howard, 2007), indicating that the compounds could be detected and 
analyzed using methodology based on existing ISTC protocols and instrumentation. 
 
Based on the stated criteria, the following compounds were selected for analysis: 
  
 Brominated compounds  
o PBCCH: 1,2,3,4,5-pentabromo-6-chlorocyclohexane, CAS# 87-84-3 
o HBCDD: 1,2,5,6,9,10-hexabromocyclododecane, CAS# 3195-55-6 
 
 Chlorinated compounds 
o HCCPD: 1,2,3,4,5,5-hexachloro-1,3-cyclopentadiene, CAS# 77-47-4 
o TCCBA: 3,4,4'-trichlorocarbanilide, CAS# 101-20-2 
 
 Fluorinated compounds 
o DCBTF: 3,4-dichlorobenzotrifluoride, CAS# 328-84-7 
o CDNBTF: 4-chloro-3,5-dinitrobenzotrifluoride, CAS# 393-75-9 
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 Non-halogenated compounds 
o TPPine: triphenylphosphine,  CAS# 603-35-0 
o TTBP: 2,4,6-tri-tert-butylphenol, CAS#732-25-3 
 
 Siloxane compounds 
o DDMPS: dodecamethylpentasiloxane, CAS# 141-63-9 
o DDMHS: dodecamethylcyclohexasiloxane, CAS# 540-97-6 
 
Difficulty was encountered in obtaining reference materials for TTBP and DDMHS. Therefore, 
TPPite was substituted for TTBP, and DDMHS was omitted from the list. 
 
Specimen Collection 
Twenty-one lake trout were salvaged from the Illinois Department of Natural Resources’ 2008 
fall lake trout spawning assessment at Waukegan and Julian’s Reefs in the Illinois waters of Lake 
Michigan. Whole lake trout were examined in the field, a unique number was assigned to each, 
and gender, length (mm), weight (g), and any tags or identifying marks were recorded. Fish 
were transported to the Lake Michigan Biological Station on wet ice and frozen upon arrival. 
Frozen fish were transported to the Forbes Natural History Building and kept frozen until 
thawed for harvest of tissues. Tags with individual fish numbers remained with the carcass until 
the final disposition. Liver, kidneys, pancreas, heart, spleen, gonads, stomachs with contents, 
and a sample of muscle with skin were removed, weighed (g), and refrozen in plastic bags. Fish 
numbers were written on each bag with an indelible marker.  
 
In addition to the whole fish, 69 ground lake trout samples were provided by Dr. Jacques 
Rinchard of the State University of New York - Brockport. These samples were collected from 
Waukegan and Julian’s Reefs in Illinois and Clay Banks near Algoma, WI, in 2008. Fish were 
given unique identifiers and stored at -80°C prior to being processed. Fish were partially 
thawed, weighed, measured, and opened to ascertain gender. Fillets were removed, skinned, 
and cut in small strips. Viscera (e.g., digestive tract, liver, spleen, kidney, gonads, and fat 
surrounding digestive tract) were removed and cut into small pieces. Fillets and viscera were 
mixed and then ground using a meat grinder. Samples were passed through the grinder two 
times to ensure a well-mixed sample. Approximately 100 g of each homogenized fish was 
stored frozen at -80oC and shipped on ice to the Illinois Natural History Survey for analysis.  
 
Gas Chromatography/Mass Spectrometry (GC/MS) Instrument Method Development 
Analysis of the standard reference materials by GC/MS was one of the initial objectives of this 
project. In order to identify and quantitate the selected analytes, it had to be demonstrated 
that they would withstand the temperatures encountered in a gas chromatograph and that 
they would fragment in the mass spectrometer to produce identifiable spectra. A second part 
of the instrumental aspect was to run a series of different concentrations of each analyte and 
determine if the responses were linear or otherwise fit some type of reproducible curve and 
the range of concentrations over which each analyte could be determined. 
 
5 
Sample analysis was performed on a high resolution Waters MicroMass AutoSpec mass 
spectrometer coupled with a Hewlett Packard 6890 gas chromatograph. The gas 
chromatograph was equipped with a Restek STX-500 15 mm x 0.25 mm ID column with a 0.15 
µm film thickness. This column was selected because it will retain nonpolar compounds and can 
withstand temperatures up to 380°C on a programmed temperature run. The injection port was 
set at 300°C for the entire chromatographic run. The column oven was programmed to hold for 
2 minutes at 50°C and then ramp up at 10°C per minute to a final temperature of 310°C, which 
it then held for 5 minutes. This is a common setup for semivolatiles, and it appeared to be 
suitable for detecting the analytes of interest. The transfer line from the gas chromatograph to 
the mass spectrometer was set at 290°C, and the ion source was set at 280°C. For the sample 
analysis, the mass spectrometer was set up to run in selected ion recording (SIR) mode at a 
resolution of 5,000 ppm. 
 
Initial compound identification via GC/MS is based on the retention time of the analyte from 
the gas chromatograph and by the spectrum obtained by running in high resolution general 
scan mode on the mass spectrometer. After this information is obtained, the system can be set 
up in SIR mode where only one or two of the masses of each of the compounds are detected. 
Running high resolution SIR enhances instrument sensitivity by increasing the selectivity of the 
mass spectrometer, increasing the time that the mass spectrometer can monitor for the 
selected masses, and by eliminating a large amount of the background noise. This in turn 
improves the signal-to-noise ratio and with it, the sensitivity. 
 
 All of the analytes were separately prepared at the 1 ng/µL (ppm) concentration, injected on 
the GC/MS, and retention time data and high resolution mass spectra were collected in the 
general scan mode. Three of the compounds, PBCCH, TCCBA, and HBCDD, were not detected at 
the 1 ng/µL level and were reinjected at the 10 ng/µl level. Spectra and structures are included 
in Appendix A. With the retention times and spectra established, it was possible to move ahead 
with development of the GC/MS method. Retention times are included in Appendix B. There 
was no significant coelution of any of the compounds, so the GC conditions as established were 
considered acceptable. The GC method is included in Appendix C. 
 
A SIR experiment was developed for the analytes. In theory, the instrument is set to measure 
one or two masses for each compound at the retention time of that compound. In practice, a 
method segment is developed to measure the masses for a number of analytes over the 
retention times of those analytes. A limiting factor is that the highest mass being detected in a 
segment cannot be more than 1.5 times the mass of the lowest mass in the segment. Outside 
this range, the sensitivity of the instrument starts to decline. Development of the mass 
spectrometer methods for the analytes of interest required setting up a total of 10 different 
method segments to accommodate the variation in masses selected for the SIR of the 
compounds. Details are provided in Appendix D. In addition, the SIR masses for each compound 
are also listed in Appendix B, and SIR chromatograms for the compounds are included in 
Appendix E. 
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With development of the gas chromatograph and mass spectrometer parameters, the analytes 
of interest could be evaluated to determine instrument minimum detection limits (MDL). 
Starting at 1,000 pg/µL (ppb), standards of each analyte were serially diluted and injected on 
the GC/MS until the compound was not detected. These MDL concentrations are listed in 
Appendix B. Calibration curves for each analyte were developed. After some work and sample 
analysis, 1 pg/µL and 400 pg/µL were chosen as the low and high standard for each analyte, 
respectively, with intermediate standards of 5, 10, 50, and 100 pg/µL. The emerging 
contaminants calibration curves for a standard set are included in Appendix F. 
 
Internal and surrogate standards were two of the quality control (QC) measures used to ensure 
the quality of the resultant data. The compounds used as the internal and surrogate standards 
were selected based on the USEPA SW846 procedures. Surrogates are used to evaluate the 
efficiency of the extraction procedure. They are compounds that are similar to the analytes of 
interest, but which are normally not found in the matrices being analyzed. The surrogates are 
introduced to all samples, including QC samples, at the beginning of the procedure and are then 
measured at the end of the instrumental run. Recoveries of the surrogates should be a 
reflection of the recoveries of the analytes that could be expected with the extraction 
procedure and instrumental analysis on the specific matrix. The surrogate recovery can be used 
to correct sample recovery values or they can simply be reported. 
 
Internal standards are used to compensate for any volumetric errors that are encountered 
when the sample extracts are introduced into the gas chromatograph. The surrogate and 
internal standards used during the development of the procedure are included in Appendix B. 
The gas chromatograph retention times and the SIR masses are also listed in the summary. 
Some of the samples analyzed in this project contained background peaks that interfered with 
some of the internal standards or surrogate standards. In those cases, compounds without the 
interference were used for the analysis. 
 
Sample Preparation 
This study’s approach to the analysis of tissue samples involved the following three major 
segments:  (1) solvent extraction of the tissue sample; (2) removal of the lipids from the 
analytes using gel permeation chromatography (GPC); and (3) additional cleanup of the extracts 
using silica gel (SG) column chromatography. 
 
Accelerated Solvent Extraction (ASE) 
As all of the analytes of interest appeared to be soluble in the ASE solvent, hexane/acetone 
(1:1), it was felt that no development work was necessary. ISTC has used the hexane/acetone 
method successfully in the past for lipophilic semivolatile analysis. A copy of the Dionex ASE 300 
Accelerated Solvent Extractor Method is in Appendix G. 
 
Gel Permeation Chromatography (GPC) 
GPC is used to separate the lipid component of the ASE extract from the analytes. Removal of 
the lipids is important as they interfere with the silica gel column chromatography. If lipids are 
injected on the GC/MS, they will quickly contaminate the instrument and cause high 
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background noise. GPC functions by size exclusion; when a sample extract is injected on the 
GPC column, the larger molecules move with the mobile phase through the column and elute 
before the smaller molecules. In general, semivolatile compounds are smaller than the lipids in 
biological samples, and so it is possible to separate the two groups of compounds by discarding 
the first volume of mobile phase that contains the lipids and then collecting the later volume of 
mobile phase that should contain the analytes of interest.  
 
The process should be optimized as there is some overlap between the elution of the lipids and 
analytes. The existing ISTC method for GPC cleanup includes discarding the first 150 mL and 
collecting the next 110 mL. To determine the elution of the emerging contaminant group of 
analytes, a mixed standard containing all of the compounds was injected on the GPC. The first 
100 mL were discarded, the second 100 mL were collected in ten 10 mL aliquots, and the third 
and final 100 mL were collected as one aliquot. The fractions were concentrated and then 
analyzed on the GC/MS. Results showed that most of the compounds eluted after 150 mL, but 
that a few, particularly DDMPS, showed up at low levels starting with the 120 mL aliquot. The 
largest portion of these compounds was recovered after 150 mL. 
 
 A spiked tissue sample was run and the first 125 mL was discarded; the next 25 mL and 
subsequent 200 mL were collected as two fractions, which were evaporated and prepared for 
analysis. GPC elution volumes are listed in Appendix B. 
 
The second aliquot (125 to 150 mL) contained enough lipid that it caused problems on the 
GC/MS. Upon closer inspection, it was determined that the actual amount of analyte present in 
the 125 to 150 mL aliquot was not substantial enough to warrant inclusion. Analysis of the third 
fraction (150 to 350 mL) yielded acceptable results. The majority of the detectable analytes 
were present, and the lipid concentration was low enough that it did not interfere with the 
instrumentation. A description of the gel permeation chromatography method is in Appendix H.  
 
Silica Gel Column Chromatography 
Two trials of different spike concentrations were set up to evaluate ISTC’s existing silica gel 
column chromatography procedure. A 10 ng/µL mixed standard containing all of the analytes 
was prepared. In the first trial, an amount equivalent to about 200 ng of each analyte/g of fish 
sample was eluted through the silica gel column. In the second, an amount equivalent to about 
500 ng of each analyte/g of fish sample was eluted through the silica gel column. The existing 
methodology was followed and three fractions were collected from each column. The first was 
eluted with 80 mL of hexane, the second was eluted with 50 mL of hexane followed by 60 mL of 
methylene chloride, and the final fraction was eluted with 100 mL of 25% acetone in methylene 
chloride.  
 
Analysis of the fractions on the GC/MS showed that essentially all of the detectable compounds 
were in the first and second fractions. A very small amount of several of the analytes were 
detected in the acetone/methylene chloride fraction, and analyses of tissue samples from this 
fraction exhibited very high background noise on the instrument and frequently would 
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contaminate the GC/MS system. Consequently, this fraction was not included in the method 
development. The fraction in which the compounds eluted are listed in Appendix B. 
 
The method was finalized by collecting one sample from the silica gel column that was eluted 
with 130 mL of hexane followed by 60 mL of methylene chloride. This approach combined 
fractions 1 and 2, which saved analyst and instrumentation time. The combined eluates were 
concentrated to 1 mL for analysis by GC/MS. A description of the silica gel column 
chromatography method is in Appendix H.  
 
Sample Extraction and Analysis 
The samples were extracted, prepared, and analyzed in batches of six. The batch size was 
determined by the sample capacity of the Accelerated Solvent Extractor (ASE), which could be 
programmed to run up to 12 samples unattended. A typical batch consisted of six samples, one 
reagent blank, one reagent blank spike, a sample plus sample duplicate, and a sample spike plus 
sample spike duplicate. Initially, the analyst would manually start the ASE to extract the reagent 
blank. After verifying correct operation of the ASE, the remaining 11 samples were extracted in 
the automated mode of operation. 
 
Existing ISTC ASE sample tracking forms were used to track the fish and quality control samples 
in each ASE run, and thereafter, each sample set was referenced back to its ASE run number. 
There were five ASE runs in this project. The ASE forms were also used to record the sample ID 
numbers and weights, surrogate spike information, sample spike information, and the results of 
the lipid determination. Copies of the five completed ASE sample tracking forms used for the 
emerging contaminant samples are in Appendix I. 
 
The samples were analyzed on the GC/MS in ASE batches, and a set of calibration standards 
were analyzed with each ASE set. A typical analytical run consisted of injecting hexane blanks 
until the system equilibrated. Suitable results were typically obtained with the second hexane 
injection. Next, the standards were injected, starting with the lowest concentration. Another 
hexane blank was injected following the high standard concentration to ensure that there was 
no contamination of the first sample. Then the reagent blank and reagent blank spike were 
injected, followed by the remaining quality control and fish samples. Another hexane blank was 
injected, and the entire calibration series were injected again starting with the lowest standard 
concentration. The run was completed with another hexane blank. Running the calibration 
series twice helped determine if there was any instrument change or drift of any type during 
the analytical run. Also with two sets, if an individual standard injection was suspect, it could be 
rejected and there would still be a standard for that concentration level. 
 
Lake Trout Samples 
The ground fish samples were utilized for method development. These samples had been 
collected from Lake Michigan near Waukegan, Illinois, and Algoma, Wisconsin. Collections 
occurred in the spring and fall near Waukegan, and in the spring, summer, and fall near Algoma. 
The head and all the skin and bones were removed, and the remaining portions of the fish were 
ground to achieve homogenous samples. A female lake trout collected near Algoma in the 
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spring was selected for the initial method development. ASE run 1 consisted of eight male fish 
collected near Algoma in the fall, and ASE run 2 consisted of eight male fish collected in the fall 
near Waukegan. 
 
A second set of samples consisted of tissues from lake trout that had been collected near 
Waukegan and Julian’s Reefs in the Illinois waters of Lake Michigan. The fish were dissected and 
muscle with skin attached, kidney, and liver tissue were examined for the analytes of interest. 
These samples composed ASE runs 3, 4, and5, for a total of 18 samples from six fish. Two 
samples of ground fish were included as the duplicate and spike samples to complete the 
quality control for the last three ASE runs. The completed ASE sample tracking forms in 
Appendix I contain the fish sample information, weights, and other pertinent information. 
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Results 
 
Quality Control Measures 
The following types of quality control were incorporated into the project: 
 Surrogate standards  
 Reagent blanks  
 Reagent blank spikes 
 Sample duplicates 
 Sample duplicate spikes 
 
Instrument problems were encountered during analysis of samples in ASE runs 1 and 2. After 
examining the internal standard areas and the surrogate recoveries, a number of samples were 
deemed unuseable and were discarded. The remaining samples from the two runs were 
combined for reporting purposes. 
 
Surrogate Standards 
Three surrogate standards were used throughout this project: trichloromethylxylene (TCMX); 
polychlorinated biphenyl congener #65 (PCB 65); and polychlorinated biphenyl congener #155 
(PCB 155). ISTC used these in the past for the analysis of lipophilic and nonpolar semivolatile 
compounds, and the standards performed satisfactorily.  
 
At 55%, the TCMX recovered low in the samples (Table 1). Conversely, PCB 65 recovered high at 
an average of 115%. In examining the chromatography and recoveries of PCB 65, there was a 
substantial peak that coeluted with PCB 65 in a number of samples. This made it impossible to 
resolve PCB 65 and get a clean integration of the peak area. In a number of samples the 
recoveries were from 140% to over 200%. This made the data from PCB 65 suspect, although it 
was included in the report. PCB 155 performed the best of the three surrogates with an average 
recovery of 84%, similar to what ISTC has experienced in the past with surrogate recoveries. 
The variation in surrogate standard recoveries illustrates the need to use more than one 
surrogate. 
 
Reagent Blanks and Reagent Blank Spikes 
One reagent blank and one reagent blank spike were included in each ASE set. Reagent blank 
preparation follows the same procedure as for a sample. The end result is a sample (or blank) 
that should not show any background contamination or interferences that are from the 
solvents, reagents, or methodology. Surrogate standards were also added to the reagent blank 
preparation at the start of the procedure. Reagent blank spikes are reagent blanks that have an 
added analyte to determine compound recovery without the sample matrix present.  
 
The analysis of reagent blank samples indicated there was a problem with several of the 
analytes (Table 1). DDMPS, HCCPD, TPPate, and TPPineO all showed peaks when they had not 
been added to the samples. This may indicate a contamination problem in one or more of the 
reagents, or that something in the reagents is interfering with the analytes at some point in the 
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analysis. An issue with the reagent spikes was the general lack of spike recoveries. Although this 
was to some degree expected as several of the compounds were not detected at the spiking 
level, the number of non-detections is inconsistent with the earlier work on the method. 
 
Sample Spikes and Sample Spike Duplicates 
Spiking samples in duplicate is a measure of the procedure’s precision capabilities when applied 
to actual samples with observed matrix backgrounds. There was a lack of spike recoveries for 
about half of the analytes (Table 2). Better recovery was expected, and for the several analytes 
that did show recoveries, the values were quite low, except for DDMPS in three samples. 
TPPate recovered up to 700 times higher than the theoretical spike level. Although this is not 
realistically possible, none of the criteria used to eliminate erroneous results was applicable to 
the TPPate results. Surrogate recovery was acceptable for PCB 155, whereas the TCMX again 
tended toward low recovery, and PCB 65 recovery was high due to the co-elution with 
unknown background peaks. 
 
 
 
Table 1. Reagent blanks and reagent blank spikes. 
 
(a) No calibration curve – compound may be present at trace levels 
(b) Interfering background peaks – compound may be present at trace levels 
(c) Trace amount detected – below quantitation limit 
(d) Compound possibly present – mass spectrometer identification out of limits and not detected 
 
 
 
 
Reagent blanks and Reagent blank spikes
ASE 1 & 2
reag blk reag reag blk reag blk reag blk reag reag blk
spk blk spk spk blk spk
Analyte % rec ng/ml % rec ng/ml % rec ng/ml % rec
DCBTF 65 0.5 9 0 25 0.3 24
DDMPS 36 5.8 78 5.5 52 16.1 10
HCCPD 3 0.7 nd 0.6 nd nd nd
TCCBA-fragment (a) nd nd nd nd nd nd nd
CDNTFMB nd nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd nd
PBCCH (a) 13 nd nd nd nd nd nd
TPPPine nd nd nd nd nd nd nd
PBCCH (b) nd nd 28 nd nd nd nd
TPPPite nd nd nd nd nd nd nd
TPPPate 15 10.6 91 30.6 41 5.8 34
TPPPine O 2 5.4 62 11.7 53 24.3 38
HBCDD 55 nd (d) nd 68 nd (d)
TCMX (surr) % recovery na 54 54 46 40 35 44
PCB 65 (surr) % recovery 52 92 106 95 74 84 123
PCB 155 (surr) % recovery 51 107 124 100 71 82 124
ASE 3 ASE 4 ASE 5
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Table 2. Sample spike and spike duplicate recovery. 
 
(a) No calibration curve – compound may be present at trace levels 
(b) Interfering background peaks – compound may be present at trace levels 
(c) Trace amount detected – below quantitation limit 
(d) Compound possibly present – mass spectrometer identification out of limits and not detected 
 
 
 
Sample duplicate analysis indicates the procedure’s precision in relation to analyte 
concentrations in actual sample matrices. In general, spiked sample duplicate recoveries were 
low or nonexistent (Table 3). DDMPS recovered well in three of four samples, whereas TPPate 
recovered extremely high in those samples. The surrogate recovery was similar to recoveries of 
the previous sample sets. PCB 155 recovered around 100%, whereas TCMX was again low, and 
PCB 65 recovered high because of background interfering peaks. 
 
Compound Response on GC/MS 
Of the nine compounds selected, only three came through the GC/MS in an acceptable manner. 
DCBTF, DDMPS, and HCCPD were detectable at 10 pg/µL or less. They produced symmetrical, 
well-shaped peaks and well-defined spectra. HBCDD worked acceptably well, but good results 
were dependent on having the injection port and front end of the column in good condition. If 
the instrument was running well, HBCDD was detectable at 10-50 pg/µL. 
 
 
 
 
Sample Spikes and Sample Spike duplicates
fish 39 fish 39 fish 39 fish 39 fish 38 fish 38 fish 38 fish 38
spk spk dup spk spk dup spk dup spk spk spk dup
spl wt. - (grams) 5.464 5.183 5.088 5.302 5.196 5.056 4.289 4.212
Analyte % rec % rec % rec % rec % rec % rec % rec % rec
DCBTF 2 4 12 12 34 45 17 24
DDMPS 16 25 101 110 100 121 56 104
HCCPD 0 0 0.55 nd 0.43 nd nd nd
TCCBA-fragment (a) (a) (a) nd nd nd nd nd nd
CDNTFMB nd nd nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd nd nd
PBCCH (a) nd nd nd 43 nd nd nd nd
TPPPine nd nd nd nd nd nd nd nd
PBCCH (b) 7 1 nd 30 48 nd 41 130
TPPPite (c) (c) nd nd nd nd (c) (c)
TPPPate 43 118 1187 1551 6548 7328 1420 2278
TPPPine O (c) (c) 90 129 76 21 (c) 39
HBCDD (d) (d) (d) (d) (d) (d) (d) (d)
TCMX (surr) % recovery na na 73 79 65 79 42 77
PCB 65 (surr) % recovery 91 96 195 213 191 210 156 292
PCB 155 (surr) % recovery 53 61 120 131 108 118 70 147
% lipid in spl 3.4 4.2 8.3 8.1 12.4 11.3 12.2 10.9
ASE 1 & 2 ASE 3 ASE 4 ASE 5
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Table 3. Sample duplicate analysis. 
 
(a) No calibration curve – compound may be present at trace levels 
(b) Interfering background peaks – compound may be present at trace levels 
(c) Trace amount detected – below quantitation limit 
(d) Compound possibly present – mass spectrometer identification out of limits and not detected 
 
 
 
PBCCH chromatographed well, but it produced two peaks, both of which were detectable at 
approximately 50 pg/µL. The spectra of the two peaks showed similar masses and 
fragmentation patterns, suggesting that the compounds were very similar in structure. It was 
not surprising to get two peaks because the reference material was a technical grade product 
that could have consisted of a mixture of isomers. PBCCH was not in the NIST spectrum library 
on the GC/MS; thus, it was not possible to identify which peak was actually the true compound, 
and so both were indicated as PBCCH. 
 
CDNTFMB did not chromatograph well and was only detectable at 200-400 pg/µL. This result 
was quite variable and was probably dependent on the condition of the GC/MS.  
 
TPPine and TPPite exhibited some degradation during the instrumental analysis. When injected 
at ppb levels, TPPine produced only one peak, which the mass spectrometer identified as 
TPPineO. The chromatography was acceptable, and TPPineO was detectable at 50 pg/µL. 
TPPine was detected when injected at a 10 ng/µL concentration, although the peak shape was 
poor, and the major component in the chromatogram was TPPineO. Injection of TPPite yielded 
two peaks, one identified as TPPite and the second identified as TPPate. Interestingly, the 
TPPite was detectable at 10 pg/µL, and the TPPate was detectable at the 50 pg/µL 
concentration of the TPPite. 
 
Sample Duplicates
fish 39 fish 39 fish 38 fish 38 fish 2 fish 2
muscle musc dup muscle musc dup muscle musc dup
spl wt. - (grams) 5.123 5.027 5.284 5.199 4.009 4.527
Analyte ng/g ng/g ng/g ng/g ng/g ng/g
DCBTF 0.1 0.2 0.0 0.0 0.1 0.0
DDMPS 1.5 2.0 2.1 1.5 1.3 1.6
HCCPD 0.2 0.3 0.1 0.1 0.4 0.4
TCCBA-fragment (a) nd nd nd nd nd nd
CDNTFMB nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd
PBCCH (a) 3.2 2.7 nd nd 0.7 0.0
TPPPine nd nd nd nd nd 0.0
PBCCH (b) nd nd nd nd nd nd
TPPPite nd nd nd nd 3.7 3.4
TPPPate 10.7 12.3 10.4 12.3 8.2 13.1
TPPPine O 8.1 4.3 3.6 3.3 12.4 13.7
HBCDD (d) nd nd nd nd nd
TCMX (surr) % recovery 69 69 76 53 52 67
PCB 65 (surr) % recovery 171 181 149 114 147 170
PCB 155 (surr) % recovery 116 131 101 71 97 101
% lipid in spl 7.4 7.2 8.7 11.0 8.7 7.7
ASE 3 ASE 4 ASE 5
15 
TCCBA was not detected at ppb levels. When injected at ppm levels, several peaks were present 
in the chromatogram, and based on their spectra, it was speculated that they were fragments 
of TCCBA. Masses of two of the fragments were selected for inclusion in the mass spectrometer 
SIR experiment. 
 
Lake Trout Tissues 
Results of the analysis of tissues from six lake trout revealed that six of the compounds were 
detected in one or more samples (Table 4; Figure 1). DCBTF was detected at very low levels in 
the tissues of two fish, and HBCCD was detected in the muscle of one fish. DDMPS was 
detected in all tissue samples from all of the fish examined (Table 4). HCCPD was observed in 
one or more tissues from all six fish; concentrations of this compound were highest in the liver 
of four of five specimens. TPPate and TPPineO were present in all tissues of four of the six fish 
examined, but only in the kidneys of two of the fish (Figure 1). These compounds were present 
in relatively high concentrations, as compared to the other chemicals detected. As with quality 
control samples, PCB 115 yielded the best surrogate recoveries. Results of analyses of fish 
samples and quality control measures of the ASE run are provided in Appendix J.  
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Table 4. Results of analysis of lake trout tissues.  
 
 
(a) No calibration curve – compound may be present at trace levels 
(b) Interfering background peaks – compound may be present at trace levels 
(c) Trace amount detected – below quantitation limit 
(d) Compound possibly present – mass spectrometer identification out of limits and not detected 
SL  The liver for Fish 11 was lost during sample preparation 
 
muscle liver kidney muscle liver kidney muscle liver kidney
spl wt. - (grams) 4.664 7.627 4.802 4.577 4.922 4.428 4.66 4.554 5.631
Analyte ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
DCBTF 0.0 0.0 0.0 nd 0.0 0.1 0.1 0.0 0.0
DDMPS 1.9 1.2 1.9 0.1 7.5 2.3 1.5 1.8 1.8
HCCPD 0.3 0.6 0.3 nd 0.9 0.3 0.3 0.7 0.2
TCCBA-fragment (a) nd nd nd nd nd nd nd nd nd
CDNTFMB nd nd nd nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd nd nd nd
PBCCH (a) nd nd nd nd nd nd nd nd nd
TPPPine nd nd nd nd nd nd nd nd nd
PBCCH (b) nd nd nd nd nd nd nd nd nd
TPPPite nd nd nd nd nd nd nd nd nd
TPPPate 39.2 12.5 51.6 nd nd 4.1 22.4 15.7 7.9
TPPPine O 17.6 10.3 12.5 5.8 24.3 10.5 5.0 19.4 9.5
HBCDD (d) nd nd nd nd nd nd nd nd
TCMX (surr) % recovery 75 113 77 6 66 47 80 73 11
PCB 65 (surr) % recovery 137 127 127 115 47 103 129 160 31
PCB 155 (surr) % recovery 99 109 100 95 109 80 115 123 23
% lipid in spl 6.7 3.2 2.4 7.8 33.7 3.4 4.7 23.4 2.1
muscle liver kidney muscle liver kidney muscle liver kidney
spl wt. - (grams) 6.01 4.141 5.342 5.668 4.105 4.609 4.515 4.455
Analyte ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g ng/g
DCBTF 0.0 SL 0.0 nd 0.0 0.0 nd 0.0 nd
DDMPS 0.8 SL 3.2 2.5 3.4 2.1 2.3 2.2 3.1
HCCPD 0.4 SL nd 0.0 1.3 0.2 0.2 0.2 nd
TCCBA-fragment (a) nd SL nd nd nd nd nd nd nd
CDNTFMB nd SL nd nd nd nd nd nd nd
TCCBA-fragment (b) nd SL nd nd nd nd nd nd nd
PBCCH (a) (d) SL nd nd nd nd nd nd nd
TPPPine nd SL nd nd nd nd nd nd nd
PBCCH (b) (b) SL nd nd nd nd 1.1 nd nd
TPPPite nd SL nd nd nd nd nd nd nd
TPPPate 18.5 SL 11.3 nd nd 6.0 45.2 21.8 10.5
TPPPine O 27.3 SL 12.9 31.0 12.5 12.8 9.3 11.6 16.8
HBCDD (d) SL nd 8.0 nd (d) nd nd (d)
TCMX (surr) % recovery 67 SL 43 0 55 37 76 83 94
PCB 65 (surr) % recovery 151 SL 88 0 156 98 128 112 144.1
PCB 155 (surr) % recovery 109 SL 79 0.4 81 73 100 100 118.4
% lipid in spl 17.9 2.8 12.6 20.4 4.8 5.7 3.6 2.2
fish 2 fish 5 fish 7
fish 11 fish 12 fish 14
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Figure 1. Emerging contaminants lake trout data. 
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Discussion 
 
Six of the nine compounds were detected in fish tissues. Siloxanes are widely used chemicals 
found in cosmetics, deodorants, hair products, moisturizers, medical implants, food additives, 
water repellants, lubricants, defoamers, and soaps. Consequently, these compounds, including 
DDMPS, may be present in biogas from landfills (Schweigkofler and Niessner, 1999) and in 
wastewater prior to aeration (Koe and Tan, 1990). DDMPS showed the highest spike recoveries 
in all compounds examined. It also chromatographed well and was one of the most sensitive 
compounds analyzed. DDMPS was detected in all but two fish tissue samples, albeit at very low 
concentrations. Although a few experimental toxicology studies exist, to the authors’ 
knowledge there were no previous accounts of DDMPS in wild biota. The presence of siloxanes 
in fish is a cause of concern as Environment Canada concluded that cyclotetrasiloxane and 
cyclopentasiloxane are toxic, persistent, and have the potential to bioaccumulate in aquatic 
organisms. Also, the European Union classifies cyclotetrasiloxane as an endocrine disruptor, 
based on evidence that it interferes with human hormone function, and a possible reproductive 
toxicant that may impair human fertility. In laboratory experiments, exposure to high doses of 
cyclopentasiloxane has been shown to cause uterine tumors and harm to the reproductive and 
immune systems. This compound can also influence neurotransmitters in the nervous system. 
However, concentrations in fish tissue in this study were very low. Considering that spike 
recoveries were quite variable and the analyte was also detected in reagent blanks, further 
investigation is warranted.  
 
DCBTF is an herbicide intermediate (Yih and Swithenbank, 1975), used to make popular 
formulations such as Blazer®, Goal®, and Tackle®. Yang et al. (1997) found this compound to be 
among the most toxic of 20 fluorine-containing compounds using the Microtox assay. This 
chemical, which recovered well in this study, was detected in only two lake trout samples at 
close to the limit of detection. Given the toxicity of this compound, the fact that it was detected 
in a large predatory fish, and the paucity of information on its presence and fate in the 
environment, additional scrutiny is warranted.  
 
HBCDD, typically added to polystyrene, has been among the more widely used of the 
brominated flame retardants, and therefore, is essentially ubiquitous in the environment (Law 
et al., 2005). This compound bioaccumulates in biota and is transferred via the aquatic food 
chain to upper-trophic-level predators (Morris et al., 2004). HBCDD has been widely 
documented in fish, including lake trout and their prey fish in Lake Ontario (Tomy et al., 2004), 
though to the authors’ knowledge, not previously in fish from Lake Michigan. HBCDD, one of 
the least sensitive compounds on the GC/MS, performed inconsistently. This compound was 
detected at a low concentration in the muscle tissue of one fish.  
 
TPPate and TPPineO were present in one or more tissues of all the fish examined at 
concentrations that were high relative to the other chemicals examined. However, spike 
recoveries for TPPate and TPPineO were erratic. Interestingly, these two compounds were not 
analytes, but were observed on the GC/MS when TPPite and TPPine were injected. Both of 
these compounds were also detected in the reagent blanks, which indicate that there was 
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background contamination or that the instrument was showing carryover of some type. The 
extremely high recovery of TPPineO in the duplicate fish spikes may have been due to the level 
of spike in the samples. Most of the spikes were added to produce a level of 80 pg/µL, as 
compared to the standards. This result was below some detection limits of some of the 
analytes. In retrospect, a spike at 300 pg/µL for these compounds may have been more 
appropriate.  
 
HCCPD is an intermediate in the production of a number of cyclodiene pesticides, which are 
persistent, bioaccumulative, and toxic to nontarget organisms, and thus are environmentally 
problematic. Most of these compounds have been banned or their use restricted. HCCPD was 
detected at low concentrations in liver samples from several of the lake trout examined. This 
result is perhaps not surprising, as this compound was also used to manufacture flame-
retardant polymers such as Dechlorane Plus, which has been found in the Great Lakes 
environment (Hoh and Hites, 2006). HCCPD was also used to produce resins, esters, rubber, 
acids, fluorocarbons, and dyes (USEPA, 2018; Podowski et al., 1991). This compound has been 
detected in the atmosphere, and apparent sources include manufacturing, incineration, and 
landfilling (USEPA, 1984). Blankenship et al. (1994) found that the incineration of 
trichloroethylene produced HCCPD. Although rapidly lost from surface water, HCCPD was 
identified in surface, drinking, and groundwater samples in the 1970s (USEPA, 2018). Recently, 
HCCPD has been observed in sewage sludge in China (Cai et al., 2007).  
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Appendix A  
Molecular Structure and Mass Spectrum of Emerging Contaminant Analytes 
 
 
 
 
Figure A1. Molecular structure of 1,2,5,6,9,10-hexabromocyclododecane. 
 
 
 
 
Figure A2. Mass spectrum of 1,2,5,6,9,10-hexabromocyclododecane.  
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Figure A3. Molecular structure of 1,2,3,4,5-pentabromo-6-chlorocyclohexane. 
 
 
 
 
Figure A4. Mass spectrum of 1,2,3,4,5-pentabromo-6-chlorocyclohexane – part 1. 
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Figure A5. Mass spectrum of 1,2,3,4,5-pentabromo-6-chlorocyclohexane – part 2. 
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Chlorinated compounds are active ingredients in personal cleansing compounds. They are also 
used as a raw material in manufacturing other chemicals, including pesticides, flame retardants, 
resins, dyes, pharmaceuticals, plastics, and so forth. 
 
 
 
Figure A6. Molecular structure of 1,2,3,4,5,5-hexachloro-1,3-cyclopentadiene. 
 
 
 
 
Figure A7. Mass spectrum of 1,2,3,4,5,5-hexachloro-1,3-cyclopentadiene. 
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Figure A8. Molecular structure of 3,4,4’-trichlorocarbanilide (triclocarban). 
 
 
 
 
Figure A9. Mass spectrum of 3,4,4’-trichlorocarbanilide. 
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Figure A10. Molecular structure of 1,2-dichloro-4-isocyanatobenzene. 
 
 
Figure A11. Mass spectrum of 1,2-dichloro-4-isocyanatobenzene, an artifact from 3,4,4’-
trichlorocarbanilide. 
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Figure A12. Molecular structure of N-(3,4-dichlorophenyl)-N-methylurea. 
 
 
 
 
Figure A13. Mass spectrum of N-(3,4-dichlorophenyl)-N-methylurea, an artifact from 3,4,4’-
trichlorocarbanilide. 
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Fluorinated compounds are used as intermediates in the manufacturing of pesticides, 
medicines, and dyes. 
 
 
 
 
Figure A14. Molecular structure of 3,4-dichlorobenzotrifluoride. 
 
 
 
 
Figure A15. Mass spectrum of 3,4-dichlorobenzotrifluoride. 
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Figure A16. Molecular structure of 4-chloro,3-5-dinitrobenzotrifluoride. 
 
 
 
 
Figure A17. Mass spectrum of 4-chloro,3-5-dinitrobenzotrifluoride. 
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Non-halogenated compounds are used in the synthesis of organic and organometalic 
compounds and as ingredients in a casting resin. 
 
 
 
 
Figure A18. Molecular structure of triphenylphosphine.                                                                     
 
 
 
 
Figure A19. Mass spectrum of triphenylphosphine. 
  
 33 
 
Figure A20. Molecular structure of triphenylphosphine oxide. 
 
 
 
 
Figure A21. Mass spectrum of triphenylphosphine oxide. 
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Figure A22. Molecular structure of triphenylphosphite. 
 
 
 
 
Figure A23. Mass spectrum of triphenylphosphite. 
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Figure A24. Molecular structure of triphenylphosphate. 
 
 
 
 
Figure A25. Mass spectrum of triphenylphosphate, an artifact of triphenylphosphite. 
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Siloxane compounds are used in cosmetics, deodorants, and defoamers. 
 
 
 
Figure A26. Molecular structure of dodecamethylpentasiloxane. 
 
 
 
 
Figure A27. Mass spectrum of dodecamethylpentasiloxane. 
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Appendix B 
Emerging Contaminants Method Development Summary 
 
Table B1. Emerging contaminants sample analysis summary. 
CAS # Compound name 
ISTC 
Abbreviation 
Standards in 
GPC 
Volume 
Silica Gel 
Fraction 
GC Retention 
Time (min) 
Masses 
for SIS 
Low conc 
on GC/MS 
328-84-7 
3,4-Dichlorobenzotrifluoride DCBTF hexane 150-250 
F1 
 
4.33 
213.9200 
215.9165 
1 ppb 
141-63-9 
dodecamethylpentasiloxane DDMPS hexane 100-200 F2 6.98 
281.0120 
369.1994 
1 ppb 
77-47-4 1,2,3,4,5,5-hexachloro-
1,3,cyclopentadiene 
HCCPD hexane 150-250 F1 9.19 
200.8698 
202.8666 
10 ppb 
101-20-2 
3,4,4’-trichlorocarbanalide 
(triclocarban) 
TCCBA 
methanol 
and 
hexane 
     
 
Two peaks detected in ppm level  
triclocarban reference standard 
TCCBA Fragment (a)  150-250 
F2+F3 
(95:5) 
9.43 
186.9641 
188.9562 
nd at ppb conc 
TCCBA Fragment (b)  No peak 
F2+F3 
(95:5) 
10.99 
160.9764 
162.9729 
nd at ppb conc 
 Triclocarban seems to be a compound that may not work on this methodology. To date, it has not been detected by GC/MS in any solution, 
including individual ppm level reference materials. Then, the determination of its fragment is not consistent. All or none of the fragments may 
show up in different samples at any time. More work is needed to correctly analyze triclocarban. 
393-75-9 
2-chloro-1,3-dinitro-5-
(trifluoromethyl)-benzene 
CDNTFMB hexane 150-250 F2 10.10 
178.0004 
210.0018 
269.9655 
200-400 ppb 
 Chlorodinitrotrifluoromethylbenzene does not chromatogram well, and the sensitivity is not good 
87-84-3 
1,2,3,4,5-pentabromo-6-
chlorocyclohexane 
 
methanol 
and 
hexane 
     
 
Two peaks detected in the 
1,2,3,4,5-penatabromo-
chlorolcyclohexane 
PBCCH(a)  150-250 F2 18.42 
306.7838 
308.8057 
50 ppb 
PBCCH(b)  150-250 F2 19.36 
352.8147 
 
50 ppb 
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CAS # Compound name 
ISTC 
Abbreviation 
Standards in 
GPC 
Volume 
Silica Gel 
Fraction 
GC Retention 
Time (min) 
Masses 
for SIS 
Low conc 
on GC/MS 
603-35-0 Triphenyl phosphine TPPine hexane nd nd 18.55 
262.0911 
 
nd at 
ppb conc 
 Triphenyl phosphine oxide TPPine O  150-250 
F2+F3 
(80:20) 
22.47 
199.0313 
277.0677 
50 ppb 
 Only observe triphenyl phosphine at high ppm levels, usually only detect triphenyl phospine oxide 
101-02-0 Triphenyl phosphite TPPite hexane 150-250 nd 19.62 
217.0479 
310.0711 
10 ppb 
 
Triphenyl phosphate TPPate  150-250 F2 21.03 
233.0357 
325.0607 
50 ppb 
Detect  triphenylphosphite and triphenyl phosphate 
3194-55-
6 
1,2,5,6,9,10-
hexabromocyclododecane 
HBCDD 
methanol 
and 
hexane 
150-250 F2 27.48 
159.1174 
239.0253 
50 ppb 
 Chromatography is better when the injection liner is new and the front of the column has been cut off 
 trichlorometaxylene (surrogate) TCMX hexane   13.47 
206.9535 
243.9194 
 
 PCB Congener# 14 (surrogate) PCB 14 hexane   14.57 
222.0003 
223.9975 
 
 PCB Congener#30 (internal std) PCB 30 Hexane   14.67 
255.9613 
257.9585 
 
 
Pentachloronitrobenzene (internal 
std) 
PCNB Hexane   15.38 
262.8392 
264.8362 
 
 PCB Congener# 65 (surrogate) PCB 65 Hexane   16.97 
289.9224 
291.9150 
 
 PCB Congener# 155 (surrogate) PCB 155 Hexane   18.24 
357.8444 
359.8415 
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Appendix C 
Gas Chromatography Method Report 
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Appendix D 
Mass Spectrometer Experiment Report 
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Appendix E 
Mass Spectrometer SIR Chromatograms 
 
 
Figure E1. Mass spectrometer SIR chromatogram for 3,4-dichlorobenzotrifluoride. 
 
 
 
 
Figure E2. Mass spectrometer SIR chromatogram for dodecamethylpentasiloxane. 
 
 
 
 
Figure E3. Mass spectrometer SIR chromatogram for 1,2,3,4,5,5-hexachloro-1,3-
cyclopentadiene. 
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Figure E4. Mass spectrometer SIR chromatogram for 1,2-dichloro-4-isocyanatobenzene, an 
artifact from 3,4,4’-trichlorocarbanilide. 
 
 
 
 
Figure E5. Mass spectrometer SIR chromatogram for N-(3,4-dichlorophenyl)-N-methylurea, an 
artifact from 3,4,4’-trichlorocarbanilide. 
 
 
 
 
Figure E6. Mass spectrometer SIR chromatogram for 2-chloro-1,3-dinitro-5-(trifluoromethyl)-
benzene. 
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Figure E7. Mass spectrometer SIR chromatogram for 1,2,3,4,5-pentabromo-6-
chlorocyclohexane – peak 1. 
 
 
 
 
Figure E8. Mass spectrometer SIR chromatogram for 1,2,3,4,5-pentabromo-6-
chlorocyclohexane – peak 2. 
 
 
 
 
Figure E9. Mass spectrometer SIR chromatogram for triphenylphosphine. 
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Figure E10. Mass spectrometer SIR chromatogram for triphenylphosphine oxide. 
 
 
 
Figure E11. Mass spectrometer SIR chromatogram for triphenylphosphite. 
 
 
 
Figure E12. Mass spectrometer SIR chromatogram for triphenylphosphate. 
 
 
 
Figure E13. Mass spectrometer SIR chromatogram for 1,2,5,6,9,10-hexabromocyclododecane. 
 
100122 400ppb std reinj
Time
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
6
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
7
100122 400ppb std reinj 7: Voltage SIR 8 Channels EI+ 
262.0911
1.50e5
17.51
18.6917.84 19.60
100122 400ppb std reinj 9: Voltage SIR 4 Channels EI+ 
277.0677
5.51e6
22.46
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
217.0479
1.18e7
19.62
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
325.0607
1.36e6
21.02
19.62
100122 400ppb std reinj 10: Voltage SIR 4 Channels EI+ 
239.0253
2.93e4
27.41
27.37
27.36
27.34
26.18
27.48
27.85
28.19
29.7229.88
Compound 7
18.55 min - TPPPine
Triphenyl Phosphine
Compound 8
19.62 min - TPPPite
Triphenyl Phosphite
Compound 9
27.41 min - HBCDD
Hexabromocyclododecane
Compound 7 artifact
22.46 min - from TPPPine injection
TPPPine O - Triphenyl Phosphine Oxide
Compund 8 artifact
21.02 min - from TPPPite injection
TPPPate - Triphenyl phosphate
100122 400ppb std reinj
Time
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
6
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
7
100122 400ppb std reinj 7: Voltage SIR 8 Channels EI+ 
262.0911
1.50e5
17.51
18.6917.84 19.60
100122 400ppb std reinj 9: Voltage SIR 4 Channels EI+ 
277.0677
5.51e6
22.46
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
217.0479
1.18e7
19.62
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
325.0607
1.36e6
21.02
19.62
100122 400ppb std reinj 10: Voltage SIR 4 Channels EI+ 
239.0253
2.93e4
27.41
27.37
27.36
27.34
26.18
.48
27.85
28.19
29.7229.88
Compound 7
18.55 min - TPPPine
Triphenyl Phosphine
Compound 8
19.62 min - TPPPite
Triphenyl Phosphite
Compound 9
27.41 min - HBCDD
Hexabromocyclododecane
Compound 7 artifact
22.46 min - from TPPPine injection
TPPPine O - Triphenyl Phosphine Oxide
Compund 8 artifact
21.02 min - from TPPPite injection
TPPPate - Triphenyl phosphate
100122 400ppb std reinj
Time
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
6
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
7
100122 400ppb std reinj 7: Voltage SIR 8 Channels EI+ 
262.0911
1.50e5
17.51
18.6917.84 19.60
100122 400ppb std reinj 9: Voltage SIR 4 Channels EI+ 
277.0677
5.51e6
22.46
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
217.0479
1.18e7
19.62
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
325.0607
1.36e6
21.02
19.62
100122 400ppb std reinj 10: Voltage SIR 4 Channels EI+ 
239.0253
2.93e4
27.41
27.37
27.36
27.34
26.18
27.48
27.85
28.19
29.7229.88
Compound 7
18.55 min - TPPPine
Triphenyl Phosphine
Compound 8
19.62 min - TPPPite
Triphenyl Phosphite
Compound 9
27.41 min - HBCDD
Hexabromocyclododecane
Compound 7 artifact
22.46 min - from TPPPine injection
TPPPine O - Triphenyl Phosphine Oxide
Compund 8 artifact
21.02 min - from TPPPite injection
TPPPate - Triphenyl phosphate
100122 400ppb std reinj
Time
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
6
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
0
4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
7
100122 400ppb std reinj 7: Voltage SIR 8 Channels EI+ 
262.0911
1.50e5
17.51
18.6917.84 19.60
100122 400ppb std reinj 9: Voltage SIR 4 Channels EI+ 
277.0677
5.51e6
22.46
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
217.0479
1.18e7
19.62
100122 400ppb std reinj 8: Voltage SIR 6 Channels EI+ 
325.0607
1.36e6
21.02
19.62
100122 400ppb std reinj 10: Voltage SIR 4 Channels EI+ 
239.0253
2.93e4
27.41
27.37
27.36
27.34
26.18
27.48
27.85
28.19
29.7229.88
Compound 7
18.55 min - TPPPine
Triphenyl Phosphine
Compound 8
19.62 min - TPPPite
Triphenyl Phosphite
Compound 9
27.41 min - HBCDD
Hexabromocyclododecane
Compound 7 artifact
22.46 min - from TPPPine injection
TPPPine O - Triphenyl Phosphine Oxide
Compund 8 artifact
21.02 min - from TPPPite injection
TPPPate - Triphenyl phosphate
 51 
 
Appendix F 
Emerging Contaminants Calibration Curves Report
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Appendix G 
Dionex ASE 300 Accelerated Solvent Extractor Method 
 
Illinois Sustainable Technology Center 
Standard Operating Procedure for Extraction of Samples 
 using the Dionex ASE ® 300 Accelerated Solvent Extractor 
 
This general procedure can be used to extract soils, sediments, and biological tissues for 
Polychlorinated biphenyls (PCBs), Organochlorine Pesticides (OCPs), Organophosphate 
Pesticides (OPPs), and Polyaromatic Hydrocarbons (PAHs) 
 
1.0 Reagents and Equipment 
 
ASE ® 300 Accelerated Solvent Extractor Operator’s Manual, Dionex Corporation, 
Document No. 031672, Revision 01, April 2000 
ASE ® 300 Accelerated Solvent Extractor  
ASE Extraction cells, 33 mL or 66 mL size 
Balance that will weigh to 0.001 grams 
Caps, green screw type for 250 mL collection bottles 
Collection Bottles, I-Chem, clear, 250 mL, with blue screw caps and Teflon® seals, or 
equivalent 
Filters, Whatman, grade D28, 30 mm circles, or equivalent 
Acetone, GC/MS grade 
Hexane, GC/MS grade 
Hydromatrix™, Varian (fired at approximately 420°C overnight) 
Surrogate Solution 
Spatulas 
 Spike Solution  
 Glass beakers, appropriate sizes 
 Glass syringes, appropriate sizes 
 Cooler, 4°C 
 Freezer, -20°C to -60°C 
 
2.0 General Comments 
 
2.1 Safety Concerns 
2.1.1 Gloves, lab coat, and safety glasses are to be worn when working in the 
laboratory. 
2.1.2 Gloves are to be worn throughout the sample cell assembly, weighing, and 
processing to prevent contamination to the sample and analyst. 
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2.2 The turn-tables on the ASE ® 300 Accelerated Solvent Extractor contain 12 
spaces. Do not attempt to manually move the turn-tables without first pressing 
the soft-key labeled “trays.” 
 
3.0 Sample Cell Assembly for all blanks, samples, spikes, reagent blank spikes, and standard 
reference material 
 
3.1 Locate the brown Dionex icon and serial number located at the bottom of the cell. 
Hand-tighten the bottom cell cap onto the body. If there is any resistance when 
threading the cap onto the cell body, try another cap. If there is resistance 
again, the threads of the cell are probably damaged and that cell should not be 
used. Thread a cap onto the top of the cell to check for damage as well. 
3.2  Place 1 cellulose filter in the cell top at a slight angle. 
3.3 Position the insertion tool over the filter and slowly push the insertion tool into 
the cell bottom. Slowly remove the insertion tool. 
3.4 Place a 2nd cellulose filter in the cell top at a slight angle. 
3.5 Again, slowly push the insertion tool into the cell bottom. Slowly remove the 
insertion tool. 
3.6  Make sure there are no gaps around the filter and the cell wall. 
 
  
4.0 Sample Weighing  
 
4.1 Accurately weigh sample into 250 mL beaker (+/- 0.1 g). 
4.2 If weighing frozen samples, do not let them thaw prior to weighing. 
4.3 Record sample information on worksheet (transfer completed worksheet to 
notebook). 
4.4 Add Hydomatrix™ to the sample beaker and use spatula to mix/chop/cut samples 
until homogenous. Do not add so much Hydomatrix™ that you will overfill the 
extraction cell when transferring. Use 66 mL cells for frozen fish and whole bird 
tissue and 33 mL cells for soils, sediments, and egg contents. 
4.5  Place the aluminum funnel over the appropriate cell and carefully load the sample 
into the cell. Gently tap the cell body to ensure uniform filling. Fill to 
approximately 10 mm from top of cell. Be sure to keep the threads on the cell 
body and cap as clean as possible so that proper assembly of cap cell will be 
possible. Misalignment may cause the cell to be improperly placed into the oven 
and cause a fault.  
4.6 Using a syringe, add the appropriate volume of surrogate solution to the sample 
before adding Hydromatirx™ to within a few millimeters of the top of the cell. 
 76 
4.7 Thread the top cell cap onto the cell body. The top cell cap should thread smoothly 
onto the body. Do not force the top cell cap onto the cell body. Forcing the top 
cell cap onto the cell body will result in a “vapor error message.” Try another top 
cell cap. If the second cell cap does not thread onto the cell body smoothly, alert 
your supervisor before continuing. 
4.8  Rinse the funnel with acetone several times and wipe dry before using on 
subsequent samples. 
 
5.0 Quality Control Samples 
 
5.1 Reagent Blank 
 
5.1.1  A reagent blank is to be run with each group. It contains no sample but is 
processed as other samples.  
5.1.2 Add Hydromatrix™ to within 10 mm of the top of the cell. 
 5.1.3 Add an appropriate volume of surrogate solution to the sample before 
adding the Hydromatrix™ to within a few millimeters of the top of the cell. 
 
 5.2 Spiked Sample and Spiked Duplicate Sample 
 
5.2.1   Select a sample in the assigned group that can be used for both the spiked 
sample and spiked sample duplicate. 
5.2.2 Prepare as for other samples, but add an appropriate volume of spike 
solution (if the surrogate analytes are not contained in the spiking 
solution, surrogate will need to be added at this point as well) to the 
samples before adding the Hydromatrix™ to within a few millimeters of 
the top of the cell. 
 
 5.3 Spiked Reagent Blank (Laboratory Control Standard, LCS) 
 
5.3.1 Prepare as for Reagent Blank. 
5.3.2 Add appropriate volume of spike solution (if the surrogate analytes are 
not contained in the spiking solution, surrogate will need to be added 
at this point as well) to the sample before adding the Hydromatrix™ to 
within a few millimeters of the top of the cell. 
 
 
5.4 Standard Reference Materials (SRMs) 
 
5.4.1 Prepare as for samples except weigh an appropriate amount of standard 
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reference material that reflects the scope of this particular project and will 
result in an analyte response that will be within the established calibration 
curves. 
5.4.2 Add an appropriate volume of surrogate solution to the sample before 
adding the Hydromatrix™ to within a few millimeters of the top of the 
cell. 
 
6.0  Loading the Sample Trays 
 
 6.1 Loading Cells into Upper Tray 
 
6.1.1 If the upper tray does not move freely, press the touch pad labeled “trays” 
located on the upper left of the control panel. The tray should now move 
freely. 
6.1.2 Load the filled cells onto the tray by hanging the cells vertically in the tray 
slots (brown Dionix icon at the bottom).  
6.1.3 Record the location of each cell in a laboratory notebook or appropriate 
worksheet. 
 
6.2 Loading Collection Bottles into Bottom Tray 
 
6.2.1 There are 12 locations on the table. If the bottom tray does not move 
freely, press the touch pad labeled “trays” located on the upper left of the 
control panel. The tray should now move freely.  
6.2.2 Label the collection bottles with the Illinois Waste Management and 
Research Center Request for Analysis (WMRC RSA) sample 
identification number using an indelible marker. Other markers will rub 
off when the collection bottles are put in the refrigerator or freezer. The 
label should be in a location on the bottle that does not obstruct the sensor 
on the collection bottle turn-table. 
6.2.3 Make sure that each collection bottle has a completely seated Teflon liner 
in the blue screw cap. The Teflon liner should face towards the sample 
when assembled. 
6.2.4 Load collection bottles into appropriate positions. 
6.2.5 Load the rinse collection bottle into the R1 position, making sure that 
there is a new liner installed in the blue screw cap. A new liner is 
necessary so that vapors do not escape and cause an error message. 
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7.0 Solvent Delivery System 
 
7.1 Solvent Preparation 
 
Note: The extraction solvent of 1:1 Acetone:Hexane is a general purpose 
solvent. Refer to Technical Notes in the Dionex manual if a select group of 
analytes are to be extracted. 
 
7.1.1 Using the graduated markings on the ASE solvent bottle, add 900 mL of 
Acetone and 900 mL hexane to the solvent bottle. Cap and swirl to mix. 
7.1.2 Open the solvent reservoir compartment door and place the solvent bottle 
in the compartment. 
 
8.0  Extraction Method 
 
8.1  Loading Extraction Method  
 
8.1.1 Method 5 is the program used to extract PCBs, OCPs, OPPs, and PAHs. 
Check the parameters in Method 5 to check that the following parameters 
are in this method:  Pressure (1500 psi), Temperature (150○C), Static Time 
(5 minutes), Flush Volume (60%), Purge Time (100 seconds), Cycles (2). 
8.1.2 Press “menu” to display the “menu of screens,” and press “enter” to 
display the “Load Method or Schedule” screen. 
8.1.3 Verify that “Method” appears in the “Load” field. If it does not, press 
“Select” (arrow) to toggle to “Method.” 
8.1.4 Observe the “BTTL” display. By default it will be “1.” To start the run on 
a different bottle, move the cursor to “BTTL” field and enter the desired 
number. 
8.1.5 Observe the current status screen to make sure that the location of the cell 
number and the location of the bottle number must be the same prior to 
the start of the run. 
8.1.6 Press “enter” to close this screen and open the “Current Status” screen. 
 
8.2  Starting Run 
 
8.2.1 Open the nitrogen cylinder and open the door of the “Solvent Reservoir 
Compartment” and check the pressure readings of the solvent bottle, 
System Air, and the Compression Oven. Refer to the ASE ® 300 
Accelerated Solvent Extractor Operator’s Manual, B.2.5 Check Pressure 
Readings, B-14. 
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8.2.2 Record the readings in the ASE ® 300 Maintenance Log Book and check 
to see if they are in line with the suggested readings and what they have 
been running over the past week or so. If the values are not within limits, 
alert supervisor before continuing. 
8.2.3 To prime the solvent lines, press the “rinse” button located on the Control 
Panel. The instrument will go through a manual rinse cycle, which can be 
observed in the “Current Status” screen. When the “System Status” shows 
“IDLE,” repeat the manual rinse procedure. Repeat until solvent is freely  
pumped into the rinse collection bottle. Two to three times is usually 
sufficient. 
8.2.4 Press the “start” button on the Control Panel.  
 
9.0 Post Run Procedure 
  
9.1 Upon completion of the run, let the sample cells cool for approximately 15 
minutes. 
 
9.2  Remove the sample cells and the collection bottles from the trays. 
 
9.3 If the extracted sample in the collection bottle is to be stored until the 
concentration step, replace the blue screw cap with a green, Teflon® lined screw 
cap and place in 4°C cooler.  
 
9.4 Turn off the nitrogen cylinder. 
 
10.0 Post-Extraction Procedures 
 
10.1 Cleaning the Cells 
 
10.1.1  Refer to the ASE ® 300 Accelerated Solvent Extractor Operator’s, 3.5.1 
Cleaning the Cells, p. 3-44. Never use the muffle furnace for this 
cleaning. Cleaning temperatures should never exceed 400°C. Cleaning the 
cell bodies and end caps should be done immediately after the cooling 
period. They should never set more than 24 hours before cleaning. If acid 
is used in the process, cell bodies and end caps should be cleaned 
immediately after the cooling period to decrease the chance of corrosion 
and damage. 
10.1.1 Gently empty cell bodies (Do not hit cell body on edge of bench or trash 
can. This will alter the shape of the cylinder opening and the cap 
won’t fit.) Use a spatula to remove material if needed. 
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10.1.2 Remove filter.  
10.1.3 Clean cell bodies with soapy water and brush, triple rinse with tap water, 
DI water, and acetone. Air dry. 
10.1.4 Rinse cell caps with copious amounts of acetone and air dry. 
10.1.5 Sonicate end caps in a beaker of acetone for 15 minutes if the cleanliness 
of the caps is in question. Do not use tongs to remove from acetone as the 
threads will get damaged. Air dry.  
 
 
11.0 References 
 
 11.1 ASE® 300 Accelerated Solvent Extractor Operator’s Manual, Dionex 
Corporation, Document No. 031672, Revision 01, April 2000 
 
11.2 U.S. EPA Method 3545, Pressurized Fluid Extraction (PFE), Revision 0, 
December 1996 
 
11.3 Dionex® Application Note 316, Extraction of PCBs from Environmental Samples 
Using Accelerated Solvent Extraction (ASE®) 
 
11.4 Extraction Procedures for the Determination of Chlorinated Hydrocarbons and 
Polychlorinated Biphenyls (PCBs) in Fish Using Sonication Extraction or 
Accelerated Solvent Extraction (ASE), Document Control No. 168, S.O.P. 
No:ORL017-01-1109, Revision No. 1, July 1, 1999 
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Appendix H 
Gel Permeation Chromatography and Silica Gel Column Chromatography 
Method 
 
 
Illinois Sustainable Technology Center 
Standard Operating Procedure for the Determination of Percent Lipid 
Content, Gel Permeation Chromatography Cleanup, and Silica Gel Cleanup 
of Fish Tissue Extractions Obtained from the Dionex ASE® 300 Accelerated 
Solvent Extractor for the Emerging Contaminant Project 
 
1.0 Scope and Application 
 
1.1 The concentrated tissue extract obtained from the Dionex ASE® 300 is used to 
determine lipid content and used for Gel Permeation Chromatography (GPC) 
Cleanup and the Silica Gel Cleanup. A portion of the concentrated extract is used 
to determine percent and total lipids, and the remaining extract is used for GPC 
and subsequent silica gel cleanup. 
1.2 GPC is a size-exclusion technique used to separate the large lipid molecules 
within the extract from the analytes of interest.  
1.3 Silica gel, deactivated to 3.3%, is used in separate analytes of interest from 
interfering contaminants using solvents of a different polarity.  
 
2.0 Apparatus and Material for Lipid Determinations 
 
2.1 Acetone rinsed, disposable aluminum dishes 
2.2 Volumetric glass pipettes, 0.5 mL 
2.3 Methylene Chloride, (Dichloromethane) CH2CL2 – GC/MS grade 
2.4 Balance that will weigh 0.0001 g. 
2.5 Volumetric flasks, 5 mL  
 
3.0 Apparatus and Material for GPC 
 
3.1 19 mm X 530mm column packed with O I Analytical, Envirobeads S-X3 Select, 
200-400 mesh, OI Part # 091-203 
3.2 HPLC Pump (Waters 501) capable of 5 mL/min. flow. 
3.3 Automated fractionation collector (Waters Fraction Collector) 
3.4 Disposable, acetone rinsed syringes, without black rubber or equivalent 
3.5 Filters, Gelman Acrodisc, CR PTFE, 0.45 um or equivalent 
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3.6 TurboVap® Vessels, 1 mL nipple 
3.7 Methylene Chloride, (Dichloromethane) CH2CL2 – GC/MS grade 
 
 
4.0 Apparatus and Materials for Silica Gel Column Cleanup 
 
4.1 Kontos® chromatographic column – 250 mm long X’S 10 mm ID; with fired 
glass wool at bottom and a PTFE stopcock. 
NOTE: Prior to use, glass wool plugs should be fired at 420°C for 4 hours. 
After firing, glass wool may be stored in sealed glass jar. 
4.2 Beakers – appropriate sizes 
4.3 Zymark TurboVap®  500 Closed Cell Concentrator 
4.4 Neslab® RTE-110 Chiller 
4.5 Zymark TurboVap® Vessels with 1 mL nipple or appropriate glass collection 
vessels. 
4.6 Collection bottles (glass) – appropriate sizes. 
4.7 Muffle furnace capable of obtaining temperatures of 420°C. 
4.8 Drying oven capable of obtaining temperatures of 130°C. 
4.9 Cooler capable of 4°C. 
 
4.10 Reagent grade inorganic chemicals, GC/MS grade solvents, and organic-free 
reagent water should be used in all tests. 
 
4.10.1 Eluting Solvents 
a. Hexane, C6H14 – GC/MS grade 
b. Methylene Chloride, (Dichloromethane) CH2CL2 – GC/MS grade 
 
4.11 Silica gel for chromatographic columns. 
 
4.11.1  500 g, 100/200 mesh (Fisher Brand grade 923 or equivalent). Before use, 
activate for at least 16 hours at 130°C in a shallow glass tray, loosely 
covered with foil.  
4.11.2 Remove from oven and cool. 
4.11.3 Place clean, appropriately labeled 500 gram jar in hood and transfer silica 
gel to jar. 
4.11.4 Deactivate the silica gel to 3.3% by adding 17 grams reagent water. 
Mix the contents thoroughly with a clean glass rod and replace lid on 
jar. Rotate jar every thirty minutes for six hours. 
4.11.5 Store in desiccator. 
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5.0 Reagents 
 
5.1 Sodium Sulfate for chromatographic columns 
 
5.1.1 Heat sodium sulfate at 420°C for at least 4 hours in a shallow tray.  
5.1.2 Cool and transfer to appropriate glass container. Store in desiccator when 
not in use.  
 
6.0 TurboVap® 500 and Neslab® RTE-110 Chiller Start-up 
 
6.1 Turn on TurboVap® 500 by pressing switch located on the lower left side of the 
unit. 
6.2 Set Turbo Vap® 500 water bath “Temp” to “40” (°C) using the digiswitches 
located on the top left panel of the unit and allow water bath to equilibrate. 
6.3 Set the “Time” to “01” using the digiswitches located on the top left panel of the 
unit. 
6.4 Set “Concentrate from start until” to “sensor endpoint” by pressing key pad 
located on the top left panel of the unit. 
 6.5 Set the “Fan” speed to “A” by pressing keypad located on the top left panel of the 
unit. 
6.6 Turn on the Neslab® chiller by pressing the “on/off” toggle located on the right 
front panel of the top unit. If temperature is not set to 5°C, set that temperature 
using the “coarse” and “fine” knobs located on the front panel of the bottom unit. 
Equilibrate to 5°C (approximately 30 minutes). 
 
 
7.0 Concentration of tissue extracts from ASE® 300, Illinois Sustainable Technology 
Center Standard Operating Procedure for Extraction of Samples using the Dionex 
ASE® 300, Accelerated Solvent Extractor 
 
7.1 Extracts may contain 2 layers: a top hexane/acetone layer and a bottom water 
layer. There may be a white precipitate between the layers. 
7.2 Carefully pour the entire contents of each respective collection bottle into an 
appropriately labeled Zymark TurboVap® vessel (1 mL nipple). Let set 15 to 20 
minutes so that the solution clears and the bottom water layer is obvious. 
7.3 Using a disposable glass pipette, transfer the bottom aqueous layer back to the 
collection bottle. 
7.4  Add approximately 10 mL of hexane to the collection vessel. 
7.5 Swirl to mix and let settle. If the solution is hazy or cloudy in the collection bottle, 
let the solution set until it has cleared. 
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7.6 Pipet the top hexane layer into the TurboVap® vessel. 
7.7 Repeat steps 7.3 to 7.5. 
7.8 Add approximately 10 g of sodium sulfate to the collection bottle and 
approximately 10 mL of hexane. 
7.9 Swirl to mix and let settle. 
7.10 Pipet the top hexane layer from the collection bottle and combine with the other 
washes in the TurboVap® vessel. 
7.11 Let the washing set for approximately 30 minutes. Observe the nipple of the 
TurboVap® vessel. Using a dispo-pipette, remove any remaining water from the 
TurboVap® vessel nipple and place in collection bottle. 
7.12 Remove black TurboVap® covers from top of unit and place the TurboVap® 
vessels in the water bath. 
7.13 Place the water tower on the top of the vessel and press the keypad labeled “in 
process.” 
7.14 Concentrate (evaporate) the extract to 1 mL using the TurboVap® 500 settings 
listed in step 6.0. 
7.15 When the sample has been evaporated to endpoint, the unit will emit a beeping 
sound. 
7.16 Press the keypad labeled “stopped,” remove the water tower from the vessel, and 
place the water tower in the holding cup. 
 
8.0 Solvent Exchange to Methylene Chloride 
 
 8.1 Using a glass dispo-pipette, rinse the sides of the TurboVap® vessel with 
approximately 3 mL of methylene chloride, being careful not to touch the pipette 
to the sides of the vessel. 
8.2  Repeat steps 7.12 through 7.15 two more times so that the sample has been 
exchanged to methylene chloride three times. 
8.3 Using a glass dispo-pipette, quantitatively transfer the sample to an appropriately 
labeled 5 mL volumetric flask using very small methylene chloride rinses. Cap 
and invert to mix. 
8.4 Transfer sample to a 7 mL or 14 mL screw-capped vial. At this point, the sample 
may be immediately used for lipid determination or placed in the cooler for further 
processing. 
 
 
 
9.0 Determination of Percent Lipids and Total Lipids 
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9.1 Clean the disposable aluminum pans with acetone and let air dry or oven dry. 
9.2  Record the sample identification on the aluminum tap. 
9.3  Zero the balance. 
9.4  Weigh the dish, recording the weight to 0.0001 g. 
9.5 Using a 0.5 mL volumetric pipette, add 0.5 mL of sample to the aluminum pan and 
let air dry for at least 2 hours or overnight. Do not perform lipid analysis on 
reagent blanks, spiked reagent blanks (LCS), sample spikes, or sample spike 
duplicates. 
9.6  Zero the balance and weigh the aluminum pan and residue. 
9.7  Calculate the percent lipids and total lipids using the following calculation: 
 
% Lipids =    {(wt. g) of pan and residue) – (wt. g.) of pan)} X 100 
                  (0.1 x sample wt. of tissue) 
 
 
Total Lipids (grams) = % Lipids x sample weight (g.) 
                                100 
 
     
10.0 Gel Permeation Cleanup (GPC) 
 
10.1 If the total lipid result is less than 1 gram, the remaining 4.5 mL may be loaded 
onto the GPC. 
10.2 If the total lipid in the sample is greater than 1 gram, the sample must be diluted 
in methylene chloride to obtain a 1 gram or less total lipid level. Subsequent 5 mL 
portions of this dilute solution will need to be loaded onto the GPC and taken 
through cleanup. Cleanup fractions may be combined. 
10.3 Fill the solvent reservoir with methylene chloride. 
10.4 Turn on the HPLC pump to 5 mL/min. flow. 
10.5 To prime the pump, insert a Luer lock glass syringe into the 1 inch plastic tube on 
the front of the HPLC pump.  
10.6 Loosen the black nut and pull on the syringe so that methylene chloride solvent 
enters the syringe barrel. While the syringe is still in the plastic tubing, close the 
black nut. Expel the solvent from the syringe into the waste beaker. Repeat this 
procedure until methylene chloride flows freely into the syringe. 
10.7 Allow the GPC column to condition for approximately 30 minutes by pumping 
methylene chloride solvent through the system. 
10.8 Check the flow out the end of the column into the waste bottle to make sure that 
solvent is being steadily pumped through the column. If solvent is not pumping 
out of the column, see the supervisor before proceeding. 
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10.9 Program fraction collector so that the first 150 mL of solvent (5 mL/min. flow X 
30 minutes = 150 mL) is diverted to waste and the next 110 mL of solvent (5 
mL/min. flow X 22 minutes = 110 mL) is collected in a Turbo Vap® vessel with 
1 mL nipple.  
10.10 Turn the sample valve to the load “L” position. 
10.11 Insert a 0.45 um filter onto the sample loop inlet. 
10.12 Insert and twist the tip of a 5 mL syringe barrel into the filter. 
10.13 Pour the sample into the syringe barrel. 
10.14 While holding the filter and sample loop inlet secure, carefully and evenly insert 
the plunger into the barrel of the syringe. 
10.15 Gently push on the plunger so that the sample is transferred through the filter and 
into the 5 mL sample loop. (Do not overfill, as you will push the sample into the 
waste beaker.) 
10.16 Turn the sample valve back to run “R” and press “start” on the fraction collector. 
10.17 Remove the filter and syringe assembly. 
10.18 Clean the outside of the inlet loop and the transfer line with three small rinses of 
methylene chloride. 
10.19 Evaporate the collected aliquot to 1 mL using the settings and procedures in 7.12 
through 7.15. 
10.20 Evaporate and exchange the methylene chloride to hexane using the TurboVap® 
settings and procedures in step 7.0 through 8.0. 
10.21 When the methylene chloride has been exchanged to hexane, quantitatively 
transfer the extract to a properly labeled 2 mL screw-cap vial using small hexane 
rinses. 
10.22 At this point the sample may be put in the freezer until the silica gel cleanup 
procedure is to be performed or continue with 11.0. 
 
 11.0 Silica Gel Cleanup Procedure 
  
 11.1 General Guidelines 
 
11.1.1 Allow the extract to reach room temperature.  
11.1.2 A layer of solvent should always be maintained at about 2 mm above the 
column to prevent gaps in the column. Use the stopcock to aid in 
regulation so that the columns are never exposed to air.  
11.1.3 Use TurboVap® vessels with a 1 mL nipple only. If PAHs are to be 
analyzed, evaporation below 0.5 mL will result in decreased recovery.  
 
11.2 Column Preparation and Conditioning 
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11.2.1 Using a small beaker, prepare a slurry of 10 g of 3.3% deactivated silica 
gel in hexane and pour into the prepared Kontos® column that has the 
stopcock open. (An open stopcock helps prevent air pockets in the 
column. Light tapping may also be used.) 
11.2.2 Rinse remaining slurry with small volumes of hexane and add to column. 
11.2.3 Let eluent drain to waste until just above the top of the column. 
11.2.4 Using a graduated cylinder, add 80 mL of hexane to the column and let 
drain to waste until just above the top of the column. 
11.2.5 Close stopcock. 
11.2.6 Place labeled collection vessel under stopcock. 
 
 
11.3 Sample Preparation 
 
11.3.1 Measure 130 mL of hexane into a beaker and set aside. 
11.3.2 Place a glass funnel into the top of the column. 
11.3.3 Quantitatively transfer sample to a small beaker containing approximately 
3 g sodium sulfate. 
11.3.4 Using the hexane from the 130 mL aliquot, rinse sample vial with three 
small volumes of hexane and add to the sodium sulfate/sample slurry. 
11.3.5 Quantitatively transfer sodium sulfate/sample slurry to the column. 
11.3.6 Using the hexane from the 130 mL aliquot, rinse sodium sulfate/sample 
beaker with three small volumes of hexane and add to column. 
11.3.7 Open stopcock and allow the sample to drain until about 2 mm above the 
sodium sulfate layer. 
11.3.8 Close stopcock. 
 
11.4 Sample Collection 
   
 11.4.1 Pour remainder of 130 mL hexane onto column. 
11.4.2 Open stopcock and collect drop-wise at a rate of 2-5 mL/min. until 
eluent is approximately 2 mm above the sodium sulfate layer. 
11.4.3 Close stopcock. 
11.4.4 Using a graduated cylinder, add 60 mL of methylene chloride onto the 
column and continue to collect eluent until approximately 2 mm above 
sodium sulfate layer. 
11.4.5 Capped samples may be stored at 4°C until further processing or continue 
with step 11.5. 
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11.5 Evaporation and Solvent Exchange of Samples 
 
11.5.1 Use TurboVap® and Chiller settings found in 6.0, TurboVap® 500 and 
Neslab® RTE-110 Chiller Start-up. 
11.5.2 If the sample has been collected in a 250 mL screw-cap bottle, 
quantitatively transfer contents to a TurboVap®, 1 mL nipple, with small 
rinses of hexane and follow procedure 7.0, step 7.12.  
11.5.3 Evaporate to 1 mL endpoint. 
11.5.4 Exchange the samples to hexane as in step 8.1 and 8.2 but on the third 
hexane solvent exchange, change the TurboVap® 500 evaporation setting 
to “set time after sensor.” 
11.5.5 Set the “Time” to “01” so that the evaporation process will stop one 
minute after the endpoint has been reached. 
11.5.6 Quantitatively transfer the extract to an appropriately labeled 1 mL 
volumetric flask using small hexane rinses. 
11.5.7 Cap and invert to mix. 
11.5.8 Transfer to an appropriately labeled 2 mL screw-capped vial and place in 
the freezer until analysis. 
 
 
12.0 References 
 
  12.1 Zymark TurboVap® 500 Closed Cell Concentrator Operator’s Manual, P/N 
47025, Rev. 2. 
12.2 Method 3630C, Silica Gel Cleanup, Revision 3, December 1996. 
12.3 Extraction Procedures for the Determination of Chlorinated Hydrocarbons and 
Polychlorinated Biphenyls (PCBs) in Fish Using Sonication Extraction or 
Accelerated Solvent Extraction (ASE), Document Control No. 168, S.O.P. 
No:ORL017-01-1109, Revision No. 1, July 1, 1999. 
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Appendix I 
ASE Sample Tracking Forms 
 
Project: ASE 1
RSA: 1209-08
Sample Extraction:
Extraction Date: te:  8/18/09  
1 Reagent Blank RBLK 0.0002 25 uL
2 Ground Fish  Fish 2 0.0399 5.560 25 uL
3 Ground Fish  Fish  4 0.0524 5. 458 25 uL
4 Ground Fish  Fish 5 0.0293 5.457 25 uL
5 Ground Fish  Fish 7 0.0639 5.389 25 uL
6 Ground Fish  Fish 18 0.0474 5.510 25 uL
7 Ground Fish  Fish 26 0.0315 5.636 25 uL
8 Ground Fish  Fish 27 0.0374 5.708 25 uL
9 Ground Fish  Fish 28 0.0692 5.554 25 uL
10  Ground Fish Spike  Fish 28 0.0437 5.201 25 uL 40 uL
11 Grnd Fish Spike Dup  Fish 28 0.0449 5.667 25 uL 40 uL
12 Spiked Reagent Blank  RBKSK  25 uL 40 uL
13 Ground Fish Dup  Fish 18 0.0484 5.417 25 uL  
1
2
3
4
5
6
7
8
9
10
11
12
ASE 300 Method:Method 5:Pressure: 1500psi, Temperature:150C, Static Time: 5 min., Flush Vol: 60%, Purge: 100 sec., Cycles: 2
Surrogate and Spike Solution Information(Solution Name, Notebook # & page, when made, etc)
Surrogate Solution 1:  2K ng/mL  TCMX,,  BZ 14,65, 155, NB 285-14, 082305, LW #2o5 in Hexane   Bk 317 p 78        TCMX;  Hexachlorob phenyl;  2,3,5,6 TCBP
Surrogate Solution 2:
Spiking Solution 1:   Book 250 page 84, 8-18-09, 10 ppm, in Hexane , JB    
Spiking Solution 2: 
Spiking Solution 3: 
Silica Gel Quality Control Solutions:
Surrogate Solution 1: 
Surrogate Solution 2:
Spiking Solution 1: 
Spiking Solution 2:
Spiking Solution 3:
ASE Tray # Comments (Liquid-Liquid Extraction, Silica Gel)
Lipid (g) in 
0.5mL  
Surr. Sol'n 1                   
2ppm
Spike Sol'n 2ppm
SK Sol'n 1                    
(5K ng/mL Mix1)
ASE Tray # Sample Wt. (g) (Wet)
SK Sol'n-2 (5K 
ng/mL Mix2)
209 Spike 
5ppm
Sample Type ISTC ID Client ID
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Project: ASE 2
RSA: 1209-08
Sample Extraction:
Extraction Date: te: 8/25/09  
1 Reagent Blank RBLK 0.0000 50uL
2 Ground Fish  Fish 10 0.0.540 4.926 50 uL
3 Ground Fish  Fish 11 0.0617 5. 168 50 uL
4 Ground Fish  Fish 20 0.0412 5..511 50uL
5 Ground Fish  Fish 21 0.0282 5.540 50 uL
6 Ground Fish  Fish 38 0.0417 5.205 50 uL
7 Ground Fish  Fish 39 0.0265 5.552 50 uL
8 Ground Fish  Fish 40 0.0440 5.139 50 uL
9 Ground Fish  Fish 43 0.0274 5.335 50 uL
10  Ground Fish Spike  Fish 39 0.0187 5.464 50 uL 40 uL
11 Grnd Fish Spike Dup  Fish 39 0.0216 5.183 50 uL 40 uL
12 Spiked Reagent Blank  RBKSK 0.0003 50 uL 40 uL
13 Ground Fish Dup  Fish 20 0.0406 5.099 50 uL  
1
2
3
4
5
6
7
8
9
10
11
12
ASE 300 Method:Method 5:Pressure: 1500psi, Temperature:150C, Static Time: 5 min., Flush Vol: 60%, Purge: 100 sec., Cycles: 2
Surrogate and Spike Solution Information(Solution Name, Notebook # & page, when made, etc)
Surrogate Solution 1:  2K ng/mL  TCMX,,  BZ 14,65, 155, NB 285-14, 082305, LW #2o5 in Hexane65, 155, 082305, LW,  of 5 in Hexane
Surrogate Solution 2: 
Spiking Solution 1:   Book 250, page 84, 8-18-09 , 10ppm, in Hexane  JBJB  
Spiking Solution 2: 
Spiking Solution 3: 
Silica Gel Quality Control Solutions:
Surrogate Solution 1: 
Surrogate Solution 2:
Spiking Solution 1: 
Spiking Solution 2:
Spiking Solution 3:
ASE Tray # Comments (Liquid-Liquid Extraction, Silica Gel)
Lipid (g) in 
0.5mL  
Surr. Sol'n 1                   
2ppm
Spike Sol'n 2ppm
SK Sol'n 1                    
(5K ng/mL Mix1)
ASE Tray # Sample Wt. (g) (Wet)
SK Sol'n-2 (5K 
ng/mL Mix2)
209 Spike 
5ppm
Sample Type ISTC ID Client ID
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Project: ASE 3
RSA: 1209-08
Sample Extraction:
Extraction Date: te:  12/8/09  
1 Reagent Blank RBLK 0.0003 50 uL
2 Muscle  Fish 5 0.0356 4.577 50 uL
3 Liver  Fish  5 0.1659 4.922 50 uL
4 Muscle  Fish 12 0.0675 5.342 50 uL
5 Liver  Fish 12 0.1154 5.668 50 uL
6 Muscle  Fish 14 0.0263 4.609 50 ul
7 Liver  Fish 14 0.0161 4.515 50 uL
8 Ground fish  38 0.0462 5.123 50 uL
9 Ground fish dup  38 0.0574 5.027 50 uL
10  Ground fish Spike  38 0.0645 5.088 50 uL 40 uL
11 Grnd fish  Spike dup  38 0.0573 5.302 50 uL 40 uL
12 Spiked Reagent Blank  RBKSK 0.0002 50 uL 40 uL
13   
1
2
3
4
5
6
7
8
9
10
11
12
ASE 300 Method:Method 5:Pressure: 1500psi, Temperature:150C, Static Time: 5 min., Flush Vol: 60%, Purge: 100 sec., Cycles: 2
Surrogate and Spike Solution Information(Solution Name, Notebook # & page, when made, etc)
Surrogate Solution 1:  1        Prepared 12/4/09            Bk 317 pg 78    TCMX; Hexachlorobiphenyl; 2,3,5,6 TCBPBk 317 p 8       TCMX;  Hexachlor biphenyl;  2,3,5,6 TCBP
Surrogate Solution 2:
Spiking Solution 1:        Prepared 12/4/09   Bk 317 pg 78    Bk 317  pg 78      P-113N  PCNB;  C-030N  2,4,6 TCBP
Spiking Solution 2: 
Spiking Solution 3: 
Silica Gel Quality Control Solutions:
Surrogate Solution 1: 
Surrogate Solution 2:
Spiking Solution 1: 
Spiking Solution 2:
Spiking Solution 3:
ASE Tray # Comments (Liquid-Liquid Extraction, Silica Gel)
Lipid (g) in 
0.5mL  
Surr. Sol'n 1                   
2ppm
Spike Sol'n 2ppm
SK Sol'n 1                    
(5K ng/mL Mix1)
ASE Tray # Sample Wt. (g) (Wet)
SK Sol'n-2 (5K 
ng/mL Mix2)
209 Spike 
5ppm
Sample Type ISTC ID Client ID
Lab accident - collection bottle broke
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Project: ASE 4
RSA:  1209-08
Sample Extraction:
Extraction Date: te:  12/14/09  
1 Reagent Blank RBLK 0.0003 50 uL
2 Muscle 09-2543 Fish 5 0.0356 4.577 50 uL
3 Liver 09-2542 Fish  5 0.1659 4.922 50 uL
4 Muscle 09-2552 Fish 12 0.0675 5.342 50 uL
5 Liver 09-2551 Fish 12 0.1154 5.668 50 uL
6 Muscle 09-2555 Fish 14 0.0263 4.609 50 ul
7 Liver 09-2554 Fish 14 0.0161 4.515 50 uL
8 Ground fish 09-2557 38 0.0462 5.284 50 uL
9 Ground fish dup 09-2558 38 0.0574 5.199 50 uL
10  Ground fish Spike 09-2559 38 0.0645 5.196 50 uL 40 uL
11 Grnd fish  Spike dup 09-2560 38 0.0573 5.056 50 uL 40 uL
12 Spiked Reagent Blank  RBKSK 0.0002 50 uL 40 uL
13   
1
2
3
4
5
6
7
8
9
10
11
12
ASE 300 Method:Method 5:Pressure: 1500psi, Temperature:150C, Static Time: 5 min., Flush Vol: 60%, Purge: 100 sec., Cycles: 2
Surrogate and Spike Solution Information(Solution Name, Notebook # & page, when made, etc)
Surrogate Solution 1:  1        Prepared 12/4/09            Bk 317 pg 78    TCMX; Hexachlorobiphenyl; 2,3,5,6 TCBPBk 317 p 8       TCMX;  Hexachlor biphenyl;  2,3,5,6 TCBP
Surrogate Solution 2:
Spiking Solution 1:        Prepared 12/4/09   Bk 317 pg 78    Bk 317  pg 78      P-113N  PCNB;  C-030N  2,4,6 TCBP
Spiking Solution 2: 
Spiking Solution 3: 
Silica Gel Quality Control Solutions:
Surrogate Solution 1: 
Surrogate Solution 2:
Spiking Solution 1: 
Spiking Solution 2:
Spiking Solution 3:
Some spilled putting into GPC.
Did not have on LOAD  when loading GPC and START was apparently not pushed but another button pushed so that time to collect is not correct. Collection started at maybe 45 minutes.
ASE appeared to have leaked some.
Sample Wt. (g) (Wet)
SK Sol'n-2 (5K 
ng/mL Mix2)
209 Spike 
5ppm
Sample Type ISTC ID Client ID
ASE Tray # Comments (Liquid-Liquid Extraction, Silica Gel)
Lipid (g) in 
0.5mL  
Surr. Sol'n 1                   
2ppm
Spike Sol'n 2ppm
SK Sol'n 1                    
(5K ng/mL Mix1)
ASE Tray #
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Project: ASE 5
RSA:  1209-08
Sample Extraction:
Extraction Date: te:  12/16/09  
1 Reagent Blank RBLK 0.0000 50 uL
2 Kidney 09-2541 Fish 2 0.0116 4.802 50 uL
3 Kidney 09-2544 Fish  5 0.0149 4.428 50 uL
4 Kidney 09-2547 Fish 7 0.0116 5.631 50 uL
5 Kidney 09-2550 Fish 11 0.0117 4.141 50 uL
6 Kidney 09-2553 Fish 12 0.0196 4.105 50 ul
7 Kidney 09-2556 Fish 14 0.0097 4.455 50 uL
8 Muscle 09-2540 Fish 2 0.0348 4.009 50 uL
9 Muscle dup 09-2540 Fish 2 0.0348 4.527 50 uL
10  Ground fish Spike 09-2559 38 0.0525 4.289 50 uL 40 uL
11 Grnd fish  Spike dup 09-2560 38 0.0461 4.212 50 uL 40 uL
12 Spiked Reagent Blank  RBKSK 0.0001 50 uL 40 uL
13   
1
2
3
4
5
6
7
8
9
10
11
12
ASE 300 Method:Method 5:Pressure: 1500psi, Temperature:150C, Static Time: 5 min., Flush Vol: 60%, Purge: 100 sec., Cycles: 2
Surrogate and Spike Solution Information(Solution Name, Notebook # & page, when made, etc)
Surrogate Solution 1:  1        Prepared 12/4/09            Bk 317 pg 78    TCMX; Hexachlorobiphenyl; 2,3,5,6 TCBPBk 317 p 8       TCMX;  Hexachlor biphenyl;  2,3,5,6 TCBP
Surrogate Solution 2:
Spiking Solution 1:        Prepared 12/4/09   Bk 317 pg 78    Bk 317  pg 78      P-113N  PCNB;  C-030N  2,4,6 TCBP
Spiking Solution 2: 
Spiking Solution 3: 
Silica Gel Quality Control Solutions:
Surrogate Solution 1: 
Surrogate Solution 2:
Spiking Solution 1: 
Spiking Solution 2:
Spiking Solution 3:
 
Did not turn to LOAD until about 1.5 mL left in the syringe..
 
Sample Wt. (g) (Wet)
SK Sol'n-2 (5K 
ng/mL Mix2)
209 Spike 
5ppm
Sample Type ISTC ID Client ID
ASE Tray # Comments (Liquid-Liquid Extraction, Silica Gel)
Lipid (g) in 
0.5mL  
Surr. Sol'n 1                   
2ppm
Spike Sol'n 2ppm
SK Sol'n 1                    
(5K ng/mL Mix1)
ASE Tray #
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Appendix J 
Quality Control and Sample Results by ASE Run 
 
ASE 1 and 2 reag blk fish 39 fish 39 fish 21 fish 38 fish 40 fish 43 fish 20 fish 39
spk spk spk dup muscle muscle muscle muscle muscle muscle
spl wt. - (grams) 5.464 5.183 5.54 5.205 5.139 5.335 5.099 5.552
Analyte % rec % rec % rec ng/g spl ng/g spl ng/g spl ng/g spl ng/g spl ng/g spl
DCBTF 65 2 4 0.2 0.2 nd nd nd nd
DDMPS 36 16 25 0.7 0.4 0.7 0.5 0.7 0.9
HCCPD 3 nd nd 2.0 2.1 0.3 0.3 0.3 0.3
TCCBA-fragment (a) nd (a) (a) (a) (a) nd (a) (a) (a)
CDNTFMB nd nd nd nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd nd nd nd
PBCCH (a) 13 nd nd nd nd nd nd nd nd
TPPPine nd nd nd nd nd nd nd nd nd
PBCCH (b) nd 7 1 nd nd nd (b) (b) nd
TPPPite nd (c) (c) nd nd nd nd 0.6 0.7
TPPPate 15 43 118 22.9 30.2 52.6 26.5 29.0 23.3
TPPPine O 2 (c) (c) 1.7 nd 5.9 3.5 3.6 12.7
HBCDD 55 (d) (d) nd nd nd nd (d) nd
TCMX (surr) % recovery na na na na na na na na na
PCB 65 (surr) % recovery 52 91 96 56 93 78 71 97 102
PCB 155 (surr) % recovery 51 53 61 42 44 60 55 67 67
% lipid in spl na 3.4 4.2 5.1 8.0 8.6 5.1 8.1 4.8
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ASE 3 reag reag blk fish 39 fish 39 fish 39 fish 39 fish 2 fish 2 fish 7 fish 7 fish 11 fish 11
blk spk muscle musc dup spk spk dup muscle liver muscle liver muscle liver
spl wt. - (grams) 5.123 5.027 5.088 5.302 4.664 7.627 4.66 4.554 6.01
Analyte ng/ml % rec ng/g ng/g % rec % rec ng/g ng/g ng/g ng/g ng/g ng/g
DCBTF 0.5 9 0.1 0.2 12 12 nd nd 0.1 nd nd SL
DDMPS 5.8 78 1.5 2.0 101 110 1.9 1.2 1.5 1.8 0.8 SL
HCCPD 0.7 nd 0.2 0.3 0.55 nd 0.3 0.6 0.3 0.7 0.4 SL
TCCBA-fragment (a) nd nd nd nd nd nd nd nd nd nd nd SL
CDNTFMB nd nd nd nd nd nd nd nd nd nd nd SL
TCCBA-fragment (b) nd nd nd nd nd nd nd nd nd nd nd SL
PBCCH (a) nd nd 3.2 2.7 nd 43 nd nd nd nd (d) SL
TPPPine nd nd nd nd nd nd nd nd nd nd nd SL
PBCCH (b) nd 28 nd nd nd 30 nd nd nd nd (b) SL
TPPPite nd nd nd nd nd nd nd nd nd nd nd SL
TPPPate 10.6 91 10.7 12.3 1187 1551 39.2 12.5 22.4 15.7 18.5 SL
TPPPine O 5.4 62 8.1 4.3 90 129 17.6 10.3 5.0 19.4 27.3 SL
HBCDD nd (d) (d) nd (d) (d) (d) nd nd nd (d) SL
TCMX (surr) % recovery 54 54 69 69 73 79 75 113 80 73 67 SL
PCB 65 (surr) % recovery 92 106 171 181 195 213 137 127 129 160 151 SL
PCB 155 (surr) % recovery 107 124 116 131 120 131 99 109 115 123 109 SL
% lipid in spl na na 7.4 7.2 8.3 8.1 6.7 3.2 4.7 23.4 17.9  
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ASE 4 reag blk reag blk fish 38 fish 38 fish 38 fish 38 fish 14 fish 14 fish 5 fish 5 fish 12 fish 12
spk muscle musc dup spk dup spk liver muscle liver muscle liver muscle
spl wt. - (grams) 5.284 5.199 5.196 5.056 4.515 4.609 4.922 4.577 5.668 5.342
Analyte Conc. % rec ng/g ng/g % rec % rec ng/g ng/g ng/g ng/g ng/g ng/g
DCBTF nd 25 0.0 0.0 34 45 nd nd nd nd nd nd
DDMPS 5.5 52 2.1 1.5 100 121 2.2 2.3 7.5 0.1 3.4 2.5
HCCPD 0.6 nd 0.1 0.1 0.43 nd 0.2 0.2 0.9 nd 1.3 0.0
TCCBA-fragment (a) nd nd nd nd nd nd nd nd nd nd nd nd
CDNTFMB nd nd nd nd nd nd nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd nd nd nd nd nd nd
PBCCH (a) nd nd nd nd nd nd nd nd nd nd nd nd
TPPPine nd nd nd nd nd nd nd nd nd nd nd nd
PBCCH (b) nd nd nd nd 48 nd nd 1.1 nd nd nd nd
TPPPite nd nd nd nd nd nd nd nd nd nd nd nd
TPPPate 30.6 41 10.4 12.3 6548 7328 21.8 45.2 nd nd nd nd
TPPPine O 11.7 53 3.6 3.3 76 21 11.6 9.3 24.3 5.8 12.5 31.0
HBCDD nd 68 nd nd (d) (d) nd nd nd nd nd 8.0
TCMX (surr) % recovery 46 40 76 53 65 79 83 76 66 6 55 0
PCB 65 (surr) % recovery 95 74 149 114 191 210 112 128 47 115 156 0
PCB 155 (surr) % recovery 100 71 101 71 108 118 100 100 109 95 81 0.4
% lipid in spl na na 8.7 11.0 12.4 11.3 3.6 5.7 33.7 7.8 20.4 12.6  
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ASE 5 reag reag blk fish 2 fish 2 fish 38 fish 38 fish 2 fish 5 fish 7 fish 11 fish 12 fish 14
blk spk muscle musc dup spk spk dup kidney kidney kidney kidney kidney kidney
spl wt. - (grams) 4.009 4.527 4.289 4.212 4.802 4.428 5.631 4.141 4.105 4.455
Analyte Conc. % rec ng/g ng/g % rec % rec ng/g ng/g ng/g ng/g ng/g ng/g
DCBTF 0.3 24 0.1 nd 17 24 nd 0.1 nd nd nd nd
DDMPS 16.1 10 1.3 1.6 56 104 1.9 2.3 1.8 3.2 2.1 3.1
HCCPD nd nd 0.4 0.4 nd nd 0.3 0.3 0.2 nd 0.2 nd
TCCBA-fragment (a) nd nd nd nd nd nd nd nd nd nd nd nd
CDNTFMB nd nd nd nd nd nd nd nd nd nd nd nd
TCCBA-fragment (b) nd nd nd nd nd nd nd nd nd nd nd nd
PBCCH (a) nd nd 0.7 0.0 nd nd nd nd nd nd nd nd
TPPPine nd nd nd 0.0 nd nd nd nd nd nd nd nd
PBCCH (b) nd nd nd nd 41 130 nd nd nd nd nd nd
TPPPite nd nd 3.7 3.4 (c) (c) nd nd nd nd nd nd
TPPPate 5.8 34 8.2 13.1 1420 2278 51.6 4.1 7.9 11.3 6.0 10.5
TPPPine O 24.3 38 12.4 13.7 (c) 39 12.5 10.5 9.5 12.9 12.8 16.8
HBCDD nd (d) nd nd (d) (d) nd nd nd nd (d) (d)
TCMX (surr) % recovery 35 44 52 67 42 77 77 47 11 43 37 94
PCB 65 (surr) % recovery 84 123 147 170 156 292 127 103 31 88 98 144.1
PCB 155 (surr) % recovery 82 124 97 101 70 147 100 80 23 79 73 118.4
% lipid in spl na na 8.7 7.7 12.2 10.9 2.4 3.4 2.1 2.8 4.8 2.2  
